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The suprachiasmatic nucleus (SCN) of the hypothalamus is the master regulator of the 
circadian clock in mammals. It generates daily rhythms of behavior, metabolism, and other 
important physiological processes. Misalignment of this internal circadian clock with the external 
environment can lead to disruption of function and disease states, such as sleep disorders, 
metabolic syndromes, and cardiovascular disease. The main driver of circadian behavior is a 
transcription-translation feedback loop of core circadian genes. Emerging evidence suggest that 
metabolic oscillators also play a crucial role in circadian rhythm generation. The discovery of a 
near-24 h oscillation of redox state in the suprachiasmatic nucleus (SCN) has put metabolism in 
the center of circadian biology (Wang et al., 2012), yet little is known about what drives the redox 
rhythm or the extent of its influence in the SCN. We hypothesize that redox oscillation is a novel 
circadian oscillator that both regulates and is regulated by the known circadian arms in the SCN 
and may play similar roles in other brain regions. Here, we propose a set of experiments to address 
the questions of what impacts the redox oscillation and what roles the redox oscillation play in 
circadian rhythm physiology. Using intra-SCN cannulation surgery to modulate the SCN in vivo 
and wheel-running behavior as an output of circadian timing, we determined that directly altering 
the SCN redox state changes the entraining effect of light on circadian behavioral rhythms of mice. 
We evaluated SCN redox state in the presence of tetrodotoxin (TTX) to block Na+-dependent 
action potentials and found that redox oscillation may be dependent upon daily rhythms of SCN 
neuronal activity. To evaluate whether redox state modulates neuronal circadian rhythms in other 
brain regions, we used real-time imaging techniques. We observed a circadian redox oscillation in 
the hippocampus that is anti-phase to that of the SCN. And similar to the SCN, the rhythm in redox 




demonstrate that 1) the SCN redox oscillation is a modulator of circadian physiology at the level 
of phase-shifting response to light, 2) the circadian redox oscillation shows interdependency with 
the molecular clock as well as neuronal activity rhythms, and 3) rhythms in redox state and 
subsequent modulation of neuronal excitability are not characteristics of only the SCN but extends 
to another brain region, the hippocampus. Overall, this study indicates the redox rhythm is a novel 
circadian oscillation that both modulates and is modulated by the known oscillators in the SCN 
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The 24 h day and night cycles generated by the Earth’s rotation has accompanied and 
driven the evolution of most organisms. As a result, all life forms, from prokaryotes to humans, 
have developed intrinsic daily rhythms in cellular processes, behavior, and metabolism. This 
endogenous near-24 h rhythm is termed circadian, from the Latin roots circa meaning “around” 
and dies meaning “day.” The self-sustained circadian oscillation provides evolutionary advantages 
as it allows organisms to coordinate their internal states to anticipate the changes in length between 
night and day and seasonally so that appropriate cellular and physiological events occur at 
appropriate times. Misalignment of the internal clock with the external environment can disrupt 
these functions and lead to disease (Davidson et al., 2006; Barnard and Nolan, 2008; Menet and 
Rosbash, 2011; Huang et al, 2011).  
The mammalian suprachiasmatic nucleus as master clock 
The mammalian circadian clock is organized hierarchically into a master oscillator and 
secondary oscillators in the brain and body. The suprachiasmatic nucleus (SCN) of the 
hypothalamus is the master circadian clock in mammals that synchronizes peripheral clocks in 
other brain regions and organ systems (Moore and Eichler, 1972; Stephan and Zucker, 1972, 
Lehman et al., 1987). The SCN is a pair of small nuclei on either side of the third ventricle, directly 
above the optic chiasm in the anterior hypothalamus (Moore, 1983) (Fig. 1.1). Each nucleus is 
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composed of approximately 10,000 tightly compacted neurons whose collective activity is 
considered to be the central “pacemaker” of circadian rhythm (Ralph et al, 1990). The SCN can 
generally be divided into a dorsomedial “shell” and a ventrolateral “core”. These two regions are 
characterized by their differential expression of peptides. The shell region expresses arginine 
vasopressin (AVP), while the core region expresses vasoactive intestinal polypeptide (VIP), and 
gastrin-releasing peptide (GRP) (Welsh et al., 2010), and little SAAS (Atkins et al., 2010). 
Destruction of the SCN results in the loss of daily rhythms in sleep-wake cycle, body temperature, 
locomotor activity, drinking, and endocrine release (Eastman and Rechtschaffen, 1983; Meyer-
Bernstein et al., 1999).  
Oscillation of clock genes and proteins in the SCN  
Circadian rhythms have been found to be generated by a transcription-translation feedback 
loop of clock genes and proteins that form an oscillatory molecular clock. This core molecular 
clock consists of a heterodimeric complex of protein products of the genes circadian locomotor 
output cycles kaput (CLOCK) and brain and muscle ARNT-like 1 (BMAL1), which positively 
regulate the expression of Period (Per1, 2, and 3) and Crypotchrome (Cry1 and 2) genes. The 
accumulated protein products form their own heterodimeric transcriptional repressor complex of 
PER and CRY to repress the activity of CLOCK and BMAL1. The transcription-translation loop 
of these core clock genes repeats with a period of approximately 24 h and is the basis for the 
mammalian molecular clock. An additional interlocking feedback loop involves the 
BMAL1/CLOCK mediated transcription of nuclear receptor genes Rev-Erba/b and RAR-related 
orphan receptor alpha (Rora). To complete the loop, REV-ERB and ROR proteins then compete 
for binding sites within the promoters of Bmal1 and CLOCK, where REV-ERB inhibits 




phosphorylation contribute to timekeeping through the destabilization of PER proteins (Ko and 
Takahashi, 2006). Post-translational modifiers like protein kinases and small molecule messengers 
such as cAMP and Ca2+ play important roles to determine and modify the intrinsic circadian 
rhythm (Gillette and Prosser, 1988; Tamaru et al., 1999; Lundkvist et al., 2005; O’Neill et al., 
2008; Atkinson et al., 2011). Together, these modifiers work to synchronize firing rate, gene 
expression, and secretion across the SCN.  
Oscillation of neuronal activity in the SCN  
Circadian rhythms in SCN electrical activity were first revealed by in vivo recordings by 
Inouye and Kawamura in 1979 (Inouye and Kawamura, 1979). The SCN neuronal population is 
nearly electrically silent at night and fire with significantly higher frequency during the day, 
peaking at midday (Prosser and Gillette, 1989; Belle et al., 2009).  This rhythm exists 
endogenously and will persist for days without input from other brain regions or the external 
environment (Green and Gillette, 1982; Groos and Hendriks, 1982; Prosser and Gillette, 1989). 
Interestingly, this high level of spontaneous action potentials occurs during the day regardless of 
whether the species is nocturnal or diurnal. The SCN is able to generate these neuronal activity 
rhythms in vivo (Meijer et al., 1998), in slice (Green and Gillette, 1982), and in dispersed cell 
culture (Welsh et al., 1995).  
Electrophysiological studies have shown that circadian oscillation is generated at the level 
of individual neurons. The spontaneous firing of SCN neurons emerges from a combination of 
intrinsic currents. These currents can be divided into those that provide excitatory drive and 
depolarization during the day, those that maintain a regular pattern of action potentials, and those 
that produce the hyperpolarization that render SCN neurons silent at night (Colwell, 2011). 




shown that the resting membrane potential of neurons in the SCN is most depolarized during 
midday and most hyperpolarized in the early night (Wang et al., 2012). The daytime depolarization 
of SCN neurons is accompanied by a decrease in overall K+ conductance while a larger K+ 
conductance at night results in hyperpolarization (Jiang et al., 1997, de Jeu et al, 1998). The 
differences in membrane potential and ionic conductances during the day and night persist even in 
the absence of synaptic activity and are likely clock-driven (Kuhlman and MacMahon, 2004). 
 Whereas neuronal activity in the SCN could be interpreted as an output of the molecular 
clock that mediates communication with other brain regions, research from the past 20 years has 
established that neuronal activity is an important component of rhythmic gene expression. A 
decade ago, a landmark study showed that electrically silencing Drosophila pacemaker neurons 
stops the free-running rhythms of core molecular clock components PERIOD and TIMELESS as 
well as behavioral activity rhythms (Nitabach et al., 2002). Furthermore, a recent study showed 
that optogenetic activation and suppression of SCN neuronal firing in mice can reset the phase and 
alter the period of the molecular clock, respectively (Jones et al., 2015). These conceptual advances 
establish that the molecular rhythm and neuronal activity rhythm are, in fact, linked as core clock 
mechanisms.  
Neuropeptides are necessary for SCN synchronicity   
Intercellular communication in the SCN is an important aspect of circadian rhythm 
generation. When SCN neurons lose communication, behavioral and neuronal firing rhythms are 
disrupted. Although individual SCN have cell-autonomous feedback in clock gene machinery, they 
rely on neuropeptides to time and synchronize expression within the SCN tissue. One of the most 
important neuropeptides responsible for synchronization in the SCN is VIP. VIP is a 28-amino 




projections to the dorsomedial SCN. VIP release is stimulated by light and therefore exhibits 
rhythmic release in light-dark environments but not in constant darkness (Shinohara et al., 1993). 
The VIP receptor (VPAC2R) is a G-protein coupled receptor highly expressed in the SCN (Cutler 
et al., 2003). Animals lacking VIP (Vip-/-) or VPAC2 (Vipr2-/-) show an absence of rhythmicity 
in neuronal firing and clock gene expression in the SCN (Aton et al., 2005; Maywood et al., 2006). 
VIP- VPAC2R signaling gives the SCN coherent rhythm and contributes to its alignment to the 
external environment.   
The SCN is aligned with the external environment 
In constant conditions, the mammalian circadian clock maintains a near 24 h intrinsic 
circadian period (t). This indicates that it corresponds to the external light-dark cycle. However, 
the period of the endogenous rhythm is not exactly 24 h and has to be adjusted to match the solar 
cycle. The intrinsic period of mice is less than 24 h, while in rats and humans it is greater than 24 
h. To properly align themselves with the outside environment, animals have to adjust their internal 
clocks to the external in a process known as entrainment. A number of environmental cues, such 
as food availability and chemical signals, can influence this process (Stephan et al., 1984; 
Golombek and Rosenstein, 2010). However, the most important external cue is light (Gillette and 
Mitchell, 2002). 
Photic information is conveyed from the eyes by a set of melanopsin-expressing 
intrinsically photosensitive retinal ganglion cells (ipRGCs) that make up the retinohypothalamic 
tract (RHT), which projects directly to the SCN (Berson et al., 2002; Hattar et al, 2002). Glutamate 
serves as the principal excitatory neurotransmitter carrying photic information encoded by ipRGSs 
to the SCN (Ding et al, 1994; Shirakawa and Moore, 1994). ipRGCs also release the 




terminals (Hannibal et al., 1997; Hannibal et al., 2000). The extent of PACAP’s role in 
photoentrainment is uncertain but studies indicate it acts as a modulator of pre- and post-synaptic 
responses to glutamate, and plays a role in the integration of light signaling (Michel et al., 2006; 
Beaulé et al., 2010).  
External cues that entrain the circadian clock are known as zeitgebers, meaning "time 
giver," and zeitgeber time (ZT) is used to describe time in reference to the external cue. On a 
lighting schedule of 12 h light and 12 h dark (LD), ZT 0 is the time of light-on and ZT 12 is the 
time of light-off. In the absence of entrainment cues, circadian time (CT) is used because events 
are timed by the internal circadian clock. For animals in constant conditions, such as a 12 h dark 
and 12 h dark (DD) lighting schedule, onset of locomotor activity is designated CT 12. Thus, CT 
0 to CT 12 is considered the subjective day while CT 12 to CT 0 is considered the subjective night.   
The endogenous circadian rhythm can reset its phase in response to entrainment cues. 
Phase shifts can occur in either direction. If the clock shifts forward in time, it is considered a 
phase advance; if the clock shifts back in time, it is considered a phase delay. The mammalian 
circadian clock is especially sensitive to signals conveying environmental light and can change its 
phasing in response to the animal's exposure to light. However, in rodents kept under constant 
darkness, the clock only responds to light encountered during the subjective night and not during 
the subjective day. Curiously, the nighttime response to light is biphasic: exposure to light in the 
early night causes phase delays in the circadian rhythm and exposure to light in the late night 
causes phase advances in the rhythm (Summer et al., 1984; Ding et al., 1994). The powerful effects 
of light on the circadian behavior are best visualized by a photic phase response curve (PRC) in 




Light exerts its effects via RHT glutamate release from the RHT, which activates the N-
methyl d-aspartate receptor (NMDA-R), leading to Ca2+ influx, activation of nitric oxide synthase 
(NOS), and finally, the release of nitric oxide (NO) (Ding et al., 1994; Watanabe et al., 1994). 
Downstream of NO release, the two pathways bifurcate and are regulated by distinct biochemical 
pathways. In early night, NO activates the ryanodine receptor (RyR), which releases Ca2+ from 
intracellular stores (Ding et al., 1998). Activation of down-stream kinases, such as cyclic-AMP 
(cAMP), Ca2+-dependent kinases, and MAP kinases, leads to the phosphorylation of Ca2+/cAMP-
response element binding protein (CREB). Phosphorylated CREB then initiates the transcription 
of the clock genes necessary for phase delay (Ding et al., 1997; Tischkau et al., 2003). In late night, 
NO cannot activate RyR and instead activates soluble guanylate cyclase (sGC). This leads to an 
increase in cyclic-GMP (cGMP) levels and activation of the cGMP-dependent protein kinase G 
(PKG) pathway, ultimately leading to CREB/CRE-activated transcription of clock genes, such as 
Per1, integral to phase advance (Liu et al., 1997; Gillette and Mitchell, 2002; Tischkau et al., 
2003). This bifurcating pathway is outlined in Figure 1.3.  
Extra-SCN clocks 
Rhythms of core clock genes are found in cells and tissues throughout the body and in 
regions of the brain outside of the SCN.  These molecular rhythms persist when cells or tissues are 
maintained in culture in the absence of the SCN.  Because non-SCN cells also contain endogenous 
molecular oscillators, the molecular circadian clock is now recognized as a fundamental 
component of all cells (Balsalobre et al., 1998; Yoo et al., 2004). One large difference between the 
SCN and peripheral oscillators is in their network properties. SCN explants are capable of 




cells from peripheral tissue can oscillate independently of one another (Welsh et al., 2004), 
coupling is found within tissues (Yoo et al., 2004).  
In complex organisms, the circadian system is comprised of multiple oscillators. Peripheral 
oscillators are not directly entrained by light, so they rely on the SCN for synchronization within 
tissues and to the external environment. Circadian oscillations have been identified within various 
structures the central nervous system. Robust rhythms in core clock gene expression and electrical 
activity are observed in extra-SCN hypothalamic nuclei, the olfactory bulb, amygdala, cerebellum, 
cerebral cortex, and hippocampus (Abe et al., 2002; Granadaos-Fuentes, 2004; Guilding et al., 
2009). These areas differ in phase, ability to sustain rhythmicity, and their relationship to the SCN. 
The SCN entrains other oscillators partly through efferent projections, but primarily through 
release of diffusible factors such as peptides and hormones (Silver et al., 1996; Mohawk et al., 
2013). Circadian oscillations in the liver and hippocampus, can be entrained by external cues other 
than light. Restricted feeding is a salient signal for entraining the circadian clocks of these 
peripheral oscillators, whereas the SCN is relatively unaffected (Loh et al., 2015).  
Circadian rhythms and metabolism  
Circadian rhythms and metabolism are inextricably linked. Food acts as a powerful 
zeitgeber and the circadian clock contributes to metabolic homeostasis by shifting physiological 
processes to accompany changes in activity (Brown and Abdelhalim, 2013). Animal models that 
lack a functional circadian clock show not only a lack of rhythmicity but also abnormal metabolic 
phenotypes (Turek et al., 2005). A large body of evidence indicates circadian rhythmicity in 
metabolism. Plasma concentrations of glucose and insulin show a day/night pattern in mammals 




addition, glucose utilization in the SCN has been shown to be rhythmic, with the highest level of 
uptake in the subjective day when SCN neuronal activity peaks (Schwartz and Gainer, 1977).  
Transcriptomic studies show that nearly half of the mouse genome oscillates with a 24 h 
rhythm in an organ-specific manner (Zhang et al., 2014). Moreover, many of the genes that show 
circadian oscillation are involved in metabolic functions (Akhtar et al., 2002; Reddy et al., 2006). 
Metabolomic screens of mice and humans have found that large amounts of metabolites are 
rhythmic even when conducted in constant environmental conditions. Furthermore, nuclear 
hormone receptors that participate in fatty acid and glucose metabolism as well as metabolic 
hormones like glucagon and insulin are all reported to display circadian oscillation (Hansen and 
Johansen, 1970; Yang et al., 2006). Most recently, work from Feeney et al. demonstrated that in 
eukaryotes, the level of intracellular Mg2+ is rhythmic (Feeney et al., 2016). What makes this 
finding so exciting is that Mg2+ is a necessary cofactor for ATP to be biologically active, thus 
giving circadian significance to global cell energetics. These combined data clearly indicate that 
metabolism is influenced by circadian rhythm and there is increasing evidence that these metabolic 
fluctuations can feed back to regulate elements of the clock.  
Cellular Redox signaling  
Energy metabolism is linked to redox homeostasis. On a cellular level, metabolic state is 
represented by the redox state. Redox is the potential to donate or receive electrons for biochemical 
processes and redox state can be defined by the balance of oxidizing and reducing potential. This 
can be evaluated by the ratio of small molecule cellular redox pairs, such as glutathione disulfide 
(GSSG)/glutathione (GSH), NAD(P)+/NAD(P)H, or dehydroascorbic acid (DHA)/ascorbic acid 
(AA) (Figure 1.4). These redox molecule pairs are sensitive to electron flow and to fluctuations in 




Cells possess multiple regulators of redox state GSH is the most abundant free thiol in cells 
and is primarily responsible for maintaining a physiological intracellular redox environment. 
Reduced GSH is oxidized to GSSG and the GSH/GSSG ratio is frequently used to assess overall 
redox state (Schafer and Buettner, 2001). The thioredoxin (Trx) system is another ubiquitous thiol 
reducing complex. Like GSH, thioredoxins serve as electron donors to reversibly reduce 
intracellular protein disulfides and maintain redox homeostasis (Arner and Holmgren, 2000).  
Peroxiredoxins (Prxs) are a family of peroxidases that scavenge and reduce hydrogen peroxide 
(H2O2) as regulators of the cellular redox environment. Mammals express six different Prx 
isoforms (Prx1–Prx6) with distinct subcellular distributions in different brain regions and cell 
types. Upon encountering H2O2, Prxs go through several levels of oxidation. The reduced thiol (-
SH) reacts to form a sulphenic acid (-SOH), then sulphinic acid (-SO2H), and a fully oxidized 
sulphonic acid (-SO3H) (Rhee, 2016). 
	 Relative to its size, the brain consumes a disproportionately large amount of O2 and is 
highly sensitive to oxidative stress and damage. Reactive oxygen species (ROS), such as H2O2, 
superoxide anion (O2-), and hydroxyl radical (HO•), are frequently implicated in oxidative damage 
and pathogenesis of disease. O2- is generated primarily as a byproduct of mitochondrial oxidative 
phosphorylation and also by NADPH oxidase (NOX) enzyme complexes (Schulz et al., 2014). 
Only moderately reactive, O2- is rapidly converted to H2O2 by superoxide dismutases. H2O2 is more 
inert and capable of diffusing through cellular membranes (Bienert et al., 2007).  In low levels, 
H2O2 can act as a local signaling molecule and in high levels, can have cytotoxic effects (Veal and 
Day, 2011). H2O2 is catalytically broken down to H2O by scavenging enzymes such as catalase, 
Prxs, or glutathione peroxidases (GPx), which keeps ROS levels contained. More reactive than 




Fenton reaction. A careful overall balance in production and neutralization of oxidants is 
maintained using a variety of mechanisms. When ROS levels rise significantly and overwhelm the 
antioxidant defense system, oxidative stress can occur and cause damage to cellular structures 
(Cross et al., 1987). However, small changes in ROS are integral to many biochemical processes. 
Accumulating evidence suggest ROS also play important roles in intracellular signal transduction 
and many physiological processes (Torres and Forman, 2003; Forman et al., 2011; Finkel, 2011). 
 Protein amino acid residues are major targets of cellular oxidants. Many of the effects of 
signaling via ROS are through the reversible modification of exposed cysteine and methionine 
residues of redox-sensitive proteins. Cysteines and methionines have reactive sulfur-containing 
side chains that make them more susceptible to redox modifications than other amino acids. The 
thiol (–SH) functional groups of cysteine residues make them especially susceptible to oxidation. 
Upon exposure to H2O2, the redox-sensitive thiol can be reversibly oxidized to reactive sulfenic 
acid (-SOH) or further oxidized to sulfinic acid (-SO2H) and irreversibly to sulfonic acid (-SO3H) 
(Comini, 2006). Non-enzymatic and reversible disulfide bond formation with a nearby cysteine is 
the most common product of -SOH cysteine oxidation (Rehder and Borges, 2010). 
The redox state of sulfur-containing amino acids are tightly regulated by GSH. GSH is a 
major source of cellular cysteine. Its linkage to redox-sensitive cysteine residues within proteins 
is termed S-glutathionylation. This transient incorporation of GSH into cellular protein via reactive 
thiols is a metabolically driven form of post-translational modification (Grek et al., 2013). Redox-
sensitive methionine residues do not form disulfide bonds and, instead, are oxidized to methionine 
sulfoxide (MetO) by a variety of different ROS (Levine et al., 1996). The reduction of oxidized 




Weissbach, 2008). The redox modification of these sulfur-containing amino acids can result in 
functional changes to protein structure and/or activity.  
Circadian-redox interactions   
 
There is compelling evidence that redox state may play a regulatory role in the circadian 
clockwork. Reduced forms of the redox cofactors NAD(H) and NADP(H) have been shown to 
enhance DNA-binding activity of the core clock proteins BMAL1 and CLOCK while their 
oxidized forms inhibit it. Even minute changes in cellular redox state can affect binding activity 
of these circadian transcriptional activators (Rutter et al., 2001). The BMAL1/CLOCK 
heterodimer regulates the expression of nicotinamide phosphoribosyltransferase (NAMPT), a rate-
limiting enzyme in the NAD+ salvage pathway (Ramsey et al., 2009). This relationship is the 
driving force for rhythmic levels of NAD+ which, in turn, activate sirtuin 1 (SIRT1) and sirtuin 3 
(SIRT3), both of which are NAD+-dependent histone deacetylases (Nakahata et al., 2009; Peek et 
al., 2013). SIRT1, an important element of metabolic control, displays circadian oscillatory activity 
and alters CLOCK function (Belden et al., 2008; Bellet et al., 2011). SIRT3 is localized in the 
mitochondrial matrix where it mediates the deacetylation of metabolic enzymes.  
Heme, a prosthetic group known to act as a sensor of cellular redox state, is another 
component in the circadian-metabolism relationship. Heme reversibly binds to the circadian 
nuclear receptors REV-ERBa and REV-ERBb in a redox state-dependent manner and modulates 
their activity, providing a link between energy sensing and an arm of the molecular clock (Carter 
et al., 2016; Gerhart-Hines and Lazar, 2015). Heme has also been shown to bind to neuronal PAS 
domain protein 2 (NPAS2), a CLOCK paralog that also binds to BMAL, and modulates its DNA-
binding activity (Dioum et al., 2002). Another link between metabolism and circadian systems 




(AMPK)-mediated phosphorylation of CRY and casein kinase I (CK1) (Lee and Kim, 2013). 
Phosphorylation of CRY results in its degradation and phosphorylation of CKIe increases its 
activity and accelerates the degradation of PER2. Most recently, Hirano et al. showed that in 
mammalian cells, CRY proteins are stabilized by the redox cofactor flavin adenine dinucleotide 
(FAD) (Hirano et al., 2017). 
The first evidence of a molecular clock-independent circadian oscillation came in the form 
of redox rhythms. Both sulphinic and sulphonic forms of peroxiredoxin are considered “hyper-
oxidized.” A circadian oscillation of the hyper-oxidized Prx proteins has been observed in red 
blood cells. The presence of this rhythm in cells that lack nuclei shows that circadian metabolic 
cycles could exist independently of the core molecular clock. However, in embryonic fibroblast 
cells from mCry1/2 -/- mice, hyper-oxidized Prx rhythms are altered (O’Neill and Reddy, 2011). 
Therefore, in nucleated cells, there is an interplay between non-translational oscillators and 
transcription-dependent oscillators. This redox cycle of Prxs was shown to be conserved across all 
domains of life, from prokaryotes to the rodent SCN (Edgar et al., 2012). These findings raise the 
possibility that rhythms in metabolism may be an ancient timekeeping oscillator (Causton et al., 
2015).   
Recent studies have identified the pentose phosphate pathway (PPP) as a regulator of 
circadian redox rhythms. Glucose utilization through the PPP is essential for replenishing the 
cytoplasmic NADPH content as well as for the generation of nucleotide and amino acid precursors. 
NADPH availability is required for the regeneration of cellular antioxidants, such as GSH, and 
prevention of oxidative stress. By pharmacological and genetic inhibition of the PPP, Rey and 
colleagues demonstrated that NADPH availability is capable of phase-resetting and altering the 




found that PPP inhibition only affects clock gene expression amplitude and phase with no changes 
in periodicity (Putker et al., 2017). These inconsistencies may be explained by the differences in 
inhibitors and cell types employed. Taken together, these data suggest that metabolic and redox 
mechanisms can modulate the core circadian clock.  
This is by no means an exhaustive list of known circadian-metabolism interactions. 
However, these findings provide strong support for metabolic regulation of the core molecular 
clock and vice versa. In mammalian systems, redox rhythms work in concert with molecular 
circadian timekeeping and have both input and output roles (Fig. 1.5).  
Circadian redox rhythms and neuronal excitability 
Corresponding circadian oscillations of redox state and neuronal excitability were observed 
in the SCN of rats and mice (Wang et al., 2012). Through measurement of FAD/NAD(P)H, 
glutathiolation, and DHA/AA ratios, Wang et al. reported that the SCN redox environment is at its 
most reduced in the mid-subjective day (CT 7) and most oxidized in the early subjective night (CT 
14). Strikingly, CT 7 corresponds to the peak in spontaneous action potentials and most 
depolarized state of membrane potential (Vm), assessed by patch clamp recording of SCN neurons. 
CT 14 corresponds to the lowest levels of spontaneous action potentials and Vm of SCN neurons 
is most hyperpolarized (Fig. 1.6). Circadian redox rhythms are not present in Bmal1-/- mice, 
suggesting that it is dependent upon a functional circadian molecular clock (Wang et al., 2012). 
Imposed changes in redox state causes immediate changes in excitability (Gillette and 
Wang, 2014). However, unlike the transcription-translation relationship between changes in the 
molecular clock and SCN physiology, redox modulates neuronal excitability by tight coupling. A 
parallel relationship between redox state and membrane potential of SCN neurons suggests 




showed that redox state regulates SCN neuronal excitability via post-translational modulation of 
K+ channels. The relatively reduced daytime environment decreases hyperpolarizing K+ currents, 
which results in membrane depolarization and increased neuronal activity. Conversely, the 
oxidized nighttime environment potentiates K+ currents, resulting in membrane hyperpolarization 
and reduced neuronal activity. Application of pharmacological blockers suggests that both leak 
and A-type K+ channels in SCN neurons are sensitive to redox environment and mediate changes 
in membrane excitability (Figure 4) (Wang et al., 2012). These findings established a new 
connection between redox state and neuronal activity in the SCN: that metabolic state could be a 
regulator, rather than only the result, of neuronal activity.  
In addition, other work from our lab has shown that redox state plays a role in regulating 
the effects of glutamate on phase shifting of the SCN circadian clock (Yu, 2007). Single unit 
activity (SUA) recording of the daily rhythm of spontaneous firing in SCN brain slices revealed 
that altering the SCN redox state could switch the directionality of glutamate-induced phase 
shifting in early and late night. Application of GSH, a reducing agent, to change the redox 
environment from oxidized to reduced before glutamate stimulation at CT 14 resulted in a phase 
advance of the neuronal activity rhythm, rather than phase delay. Furthermore, application of 
diamide (DIA), an oxidizing agent, to change the redox state from reduced to oxidized before 
glutamate stimulation at CT 19 resulted in phase delay instead of phase advance.  
Together, these findings demonstrate a critical role for metabolic state in circadian clock 
physiology. Redox oscillation appears to be a novel circadian oscillator that may be an integral 
component of the circadian clockwork. The governing forces of redox oscillation and the extent 
of its regulatory role are unknown. We seek to learn more about the circadian machinery required 










Figure 1.1 The mammalian circadian clock is in the suprachiasmatic nucleus (SCN) of the 
anterior hypothalamus. The SCN is a pair of small hypothalamic nuclei on either side of the third 










Figure 1.2 The response of circadian rhythms to light stimulus depends on the subjective 
time. In a phase response curve, the degree of phase shift is plotted against the CT time a stimulus 
is given. This is a curve generated from measurement of wheel-running behavior in rats in response 
to a 1 h light pulse of 100 lux. In constant darkness absent of external cues, the animal’s circadian 
clock continues to keep time. In the subjective day, the animal is unresponsive to light stimulus. 
In the subjective night, light stimulus in early night induces a phase delay while light stimulus in 












Figure 1.3 Pathway elements of light/glutamate-induced phase shift in the SCN. Exposure to 
light stimulates glutamate release from the retinohypothalamic tract (RHT), which activates the N-
methyl d-aspartate receptor (NMDA-R) of the SCN neurons, leading to Ca2+ influx, activation of 
nitric oxide synthase, and subsequent nitric oxide (NO) release. Downstream of NO, the two 
pathways bifurcate. In early night, NO activates the ryanodine receptor (RyR), resulting in a phase 
delay. In late night, NO activates soluble guanylate cyclase (sGC), resulting in phase advance 
























Figure 1.4. Cellular redox state is determined by several redox cofactor pairs. Redox state 
can be evaluated by the balance of small molecule redox cofactor pairs that are sensitive to the 
oxidizing/reducing potentials of the cell. These reversible reactions are regenerated enzymatically. 
Depicted are glutathione disulfide (GSSG)/glutathione (GSH), nicotinamide adenine dinucleotide 
(NAD+/NADH), nicotinamide adenine dinucleotide phosphate (NADP+/NADPH), and 




























Figure 1.5 Interactions between cellular metabolism and the circadian molecular clock. The 
core molecular clock consists of positive elements such as circadian locomotor output kaput 
(CLOCK) and brain and muscle ARNT-like 1 (BMAL1) that positively regulate the expression of 
PERs and CRYs, which then repress the activity of CLOCK and BMAL1 and comprise the 
negative arm of the clock. An additional feedback loop involves the BMAL1/CLOCK mediated 
transcription of REV-ERB and RAR-related orphan receptor (ROR) proteins that inhibit and 
initiate Bmal1 transcription, respectively. Casein kinase 1 (CK1) enzymes contribute to 
timekeeping through phosphorylation and destabilization of period (PER) proteins. Reduced forms 
of NAD(H) and NADP(H) enhance DNA binding activity of BMAL1 and CLOCK while oxidized 
NAD+ and NADP+ inhibit DNA binding. Nicotinamide phosphoribosyltransferase (NAMPT) is a 
rate-limiting enzyme in the NAD+ biosynthesis pathway and is the driving force for rhythmic levels 
of cellular NAD+ which, in turn, activate NAD+-dependent histone deacetylases, sirtuin 1 (SIRT1) 
and sirtuin 3 (SIRT3). SIRT1 has been found to exhibit circadian oscillatory activity and alter 
clock gene expression. SIRT 3 is located in the mitochondria where it mediates metabolic 
processes. Heme is a known sensor of cellular redox state that binds to nuclear receptors REV-
ERBa and REV-ERBb and modulates their activity. AMP-activated protein kinase (AMPK) is an 
important sensor of cellular energy state activated by a high AMP/ATP ratio. AMPK mediates 
phosphorylation of CRY and CK1. Phosphorylation of CRY marks it for degradation and 
phosphorylation of CK1 increases its activity and accelerates degradation of PER2. The balance 
between ROS levels and antioxidant defense systems, such as peroxiredoxins (Prx) and glutathione 












































Figure 1.6 Redox state and neuronal excitability oscillations are parallel in the SCN. The 
SCN exhibits a 24 h rhythm in spontaneous activity. The peak of SAP occurs at CT 7, the mid-
subjective day, and lowest level of SAP occurs at CT 14, early subjective night (top). Evaluation 
of redox state measured via glutathiolation levels shows the SCN is most reduced at CT 7 and most 
oxidized at CT 14 (middle). Vm assessed by patch clamp of SCN neurons show a 24 h rhythm in 
excitability (bottom). Vm is most depolarized at CT 7 and most hyperpolarized at CT 14 (Gillette 













ALTERING THE SCN REDOX STATE CAN INFLUENCE DIRECTIONALITY OF CLOCK 






One of the hallmarks of circadian entrainment is the differential phase response of the 
circadian clock to light depending on when the stimulus is applied. The circadian system does not 
respond to light stimulus during the subjective day and responds to light differently depending on 
the time of night. In early night, exposure to light produces a phase delay and in late night, exposure 
to light produces a phase advance. It is not entirely understood what gates the mechanisms that 
determine if the circadian phase will shift forward or backward in time. Previous work done in our 
lab revealed a circadian oscillation of redox state in the SCN and showed that the early night is 
relatively oxidized while the late night is relatively reduced. They demonstrated that altering the 
redox state in early and late night could flip the direction of glutamate-induced phase shifting of 
neuronal activity rhythms in the SCN slice (Yu, 2007). To elucidate the role of the SCN redox 
state on light entrainment behavior of intact animals, we chemically altered the redox environment 
of the SCN and observed its effects on light-induced phase shifting of mouse activity rhythms. We 
found that flipping the redox environment from oxidized to reduced in early night results in the 
blocking of the light-induced phase delay of wheel-running activity rhythms in mice. However, 
flipping the redox environment from reduced to oxidized in late night did not result in significant 
blocking of the light-induced phase advance due to the small phase advance of C57Bl/6 mice. Our 
results demonstrate that the SCN redox environment can regulate directionality of phase shifting 





The mammalian circadian clock expresses sensitivity to signals from the eyes 
communicating the presence of light at night, and adjusts its phasing in return. This response to 
light is biphasic: exposure to light during the early night results in phase delay of rhythms, whereas 
exposure to light during the late night results in phase advance (Daan and Pittendrigh, 1979; 
Summer et al., 1984). Glutamate is the principal neurotransmitter for light, responsible for 
conveying information from specialized photosensitive cells of the retina to the SCN (Ding et al., 
1994). Glutamate release activates the N-methyl d-aspartate receptor (NMDA-R) of neurons, 
resulting in Ca2+ influx and activation of nitric oxide synthase and nitric oxide (NO) production 
(Ding et al., 1994; Watanabe et al., 1994; Weber et al., 1995). Downstream of NO release, the 
signaling pathway bifurcates. In the early night, NO activates the ryanodine receptor (RyR); 
whereas in the late night, NO activates soluble guanylate cyclase (sGC) (Mathur et al., 1996; Ding 
et al., 1998; Weber et al., 1995). The different downstream targets determine directionality of the 
phase shift. Activation of RyR results in phase delay and activation of sGC results in phase advance 
(Ding et al., 1998). Despite the advances made in elucidating these pathways, it is still unclear how 
selective activation of RyR or sGC at different times of night is achieved.  
There is, however, ample evidence to suggest that the activities of both RyR and sGC are 
sensitive to the cellular redox environment. RyRs are Ca2+ channels embedded in the membrane 
of the endoplasmic reticulum and are responsible for release of Ca2+ from intracellular stores. RyR 
are susceptible to many posttranslational modifications, with redox modification being one of 
them. The sulfhydryl groups of RyR cysteine residues are subject to reversible S-nitrosylation and 
S-glutathionylation, which can affect channel structure and activity. Additionally, it has been 




opposite effect (Marengo et al., 1998; Xu et al., 1998; Sun et al., 2008). sGC is also a well-
characterized receptor for NO involved in numerous cell signaling pathways via the production of 
the second messenger: cyclic guanosine monophosphate (cGMP). It is typically found as a 
heterodimer consisting of an a-subunit and a heme-binding b-subunit. NO-induced activation of 
sGC requires binding of NO to the reduced ferrous form of the b-subunit heme moiety as well as 
to reduced thiol groups of sGC cysteines (Fernhoff et al., 2009). Thus, both sites of NO-activation 
are susceptible to oxidation. Furthermore, a number of studies have demonstrated that oxidants 
can inhibit sGC activity (Braughler et al., 1983; Sayed et al., 2007).  Interestingly, both RyR and 
sGC are sensitive to redox state but in opposite directions. It appears that RyR is most active under 
oxidizing conditions and sGC is most active under reducing conditions. These properties make 
redox state a potential regulator of this bifurcating pathway, responsible for the activation of RyR 
in early night and sGC in late night.  
We examined the relative redox states of the rodent SCN in early and late night by western 
blot analysis for glutathiolation and indeed found a more oxidized state in early night and a more 
reduced state in late night. Using single-unit activity (SUA) recording to assess phasing of the 
neuronal activity rhythm in SCN brain slices, Dr. Yanxun Yu, a former graduate student, found 
that changing the redox environment alters directionality of glutamate-induced phase shifting in 
early and late night. The daily rhythm of SCN neuronal activity reaches its maximum in the middle 
of the subjective day at CT 7 (Fig. 2.1A, Fig. 2.1E). In the early night (CT 14), application of 
glutamate induced a phase delay (Fig. 2.1B). However, incubation with 1 mM glutathione (GSH), 
an endogenous reducing agent, prior to glutamate treatment at CT 14 resulted in a phase advance 
(Fig. 2.1C). In the late night (CT 19), application of glutamate induced a phase advance (Fig. 2.1F). 




induced phase delay (Fig. 2.1G). Application of GSH or DIA alone did not result in a phase shift 
in early night or late night (Fig. 2.1D, 2.1H). These data suggest that the relative redox state is a 
major determinant of the SCN’s response to glutamate.  
Circadian rhythms and behavior are intimately linked. Behavioral experiments based on 
wheel-running activity have long been used as an output of circadian activity and are an especially 
useful way to examine phase shifting in response to light. In this study, we demonstrate that 
changing the SCN redox state from oxidized to reduced in early night and from reduced to oxidized 
in late night in intact animals does not flip the direction of light-induced phase shifting but rather 
blocks the shift. Here, we show that altering redox state can gate the directionality of acute light-
induced phase shifting in vivo. 
 
MATERIALS AND METHODS 
Animals 
Long Evans/BluGill rats between 8-16 weeks of age and C57Bl/6 mice were used for this 
study. Breeding colonies were generated and maintained at the University of Illinois at Urbana-
Champaign. Animals were housed under standard conditions on a 12 h light and 12 h dark (LD) 
schedule and given food and water ad libitum. All animal procedures were approved by the 
UIUC Institutional Animal Care and Use Committee.  
Glutathiolation assay 
500 µm-thick coronal hypothalamic brain slices containing the SCN were made on a 
mechanical tissue chopper and the SCN were isolated with a 2 mm-diameter tissue punch for rats 
or a 1 mm-diameter tissue punch for mice. The SCN slices were maintained in a tissue chamber 




250 µM biotinylated glutathione ethyl ester (BioGEE, Invitrogen, Carlsbad CA) for 1 h before 
collection. Samples were collected immediately post-treatment, flash-frozen on dry ice, and stored 
at -80°C until processing. Each frozen sample was mixed with 50 µL RIPA buffer for rat SCN and 
30 µL RIPA buffer for mouse SCN (50 mM Tris pH 7.5, 150 mM NaCl, 1mM EDTA, 0.2% SDS, 
1% NP-40, 0.5% sodium deoxycholate) with 1X cOmplete protease inhibitor cocktail (Roche, 
Basel SUI) on ice and mechanically homogenized. After 2 min incubation on ice, samples were 
centrifuged at 14,000 RPM and the supernatant was transferred to a clean tube. Protein 
concentration was determined by BCA protein assay (Pierce, Rockford IL). Total protein (25 
µg/sample) was resolved in 8% SDS-PAGE and transferred to nitrocellulose membrane (Bio-Rad, 
Hercules CA). Membranes were probed with 1:2000 mouse anti-biotin peroxidase antibody 
(Cellsignaling, Danvers MA) overnight and developed with SuperSignal chemiluminescent 
substrate (Pierce, Rockford IL). Blots were stripped with Restore Western Blot Stripping Buffer 
(Thermofisher, Rockford IL) and re-probed with anti-a-tubulin antibody (Cellsignaling, Danvers 
MA). Level of BioGEE incorporation was determined by the ratio of overall biotin intensity over 
the band intensity of tubulin and normalized to the maximum value of the same blot.  
Intra-SCN cannulation surgery 
Male C57Bl/6 mice were maintained on a LD schedule and given food and water ad 
libitum. Surgeries were performed at approximately 6 weeks of age (18-22 g). Animals were given 
an intraperitoneal (IP) injection of carprofen (5 mg/kg) at least 1 h prior to the procedure and 
secured into a stereotaxic frame under deep anesthesia (1-2% isoflurane). A guide cannula (26 ga, 
11.2 mm, Plastics One, Roanoke VA) was inserted into the exposed skull at coordinates 
experimentally determined from bregma (anterior-posterior: -0.1 mm, medial-lateral: -0.2 mm, 




was inserted near the cannula and both stabilized with cranioplastic cement. The animals received 
an additional post-operative IP injection of carprofen (5 mg/kg) and were allowed to recover for 
10 days.  
Wheel-running behavior and injections   
The endogenous clock maintains circadian rhythms even in the absence of external cues. 
This is seen in mice housed in constant darkness as they continue to display strong subjective 
day/night activity rhythms in the absence of light. Upon recovery from surgery, the cannulated 
mice were placed in cages equipped with running wheels (14.5 cm) in a well-ventilated and light-
tight housing system in constant darkness (DD). Each wheel rotation was recorded by a magnetic 
switch and sent to a computer with LabVIEW software (National Instruments, Austin TX). The 
data was then plotted into an actogram using Clocklab (Actimetrics, Wilmette IL). Onset of 
activity, typically occurring at CT 12, was used to observe determine phase changes in the clock. 
Once the animals have established a clear free-running rhythm in DD for 10 days, drug treatments 
were given under dim red light (<1 lux) alone or administered immediately before a light pulse 
(20 lux, 5min). Mice were gently restrained and a 1 µL Hamilton syringe fitted with a 33 ga injector 
extending 3.4mm below the guide cannula was inserted, a volume of 300 nL of GSH (10 mM) or 
artificial cerebral spinal fluid (aCSF) was given at CT 14 alone or immediately before a light pulse. 
Mice were returned to DD to resume wheel-running behavior. Magnitudes of phase shifts were 
determined by measuring the difference between regression lines plotted against activity onset 10 
days before and after treatment.  
Experimental paradigm  
To determine the effects of altering the redox environment in vivo, we injected redox 




a cannula directly above the SCN to guide an injector. Stereotaxic coordinates were determined 
by experimentally adjusting measurements and confirmed by histology (Fig. 2.5). In mice, 
individual suprachiasmatic nuclei are very small (~ 300 µm medial-lateral, 350 µm dorsal-ventral, 
600 µm rostral-caudal) and consequently difficult to target. Our success rate was approximately 
50%. Animals in which injections missed the SCN were compared as controls. Experimental 
animals were entrained to a LD light schedule for two weeks and then placed in constant darkness 
to free-run. Each animal received an initial light pulse (20 lux, 5 min at CT 14 or 100 lux, 10 min 
at CT 22) to gauge the phase shift response to light, followed by one of four treatments (vehicle, 
10 mM GSH alone, vehicle + light pulse, 10 mM GSH + light pulse at CT 14 or vehicle, 50 mM 
DIA alone, vehicle + light pulse, 50 mM DIA + light pulse at CT 22. Each treatment is 
administered under dim red light and at least 10 days apart (Fig. 2.6). The order was varied for 
different subjects. The onset of wheel-running was compared before and after treatment to assess 
change in clock phase (Fig. 2.8A, Fig. 2.9A). 
Histology 
Upon completion of the experiment, injection sites were verified by injection of 300 nL of 
0.1% methylene blue dye into the guide cannula.  Brains were removed and fixed in 4% 
paraformaldehyde. 50 µm serial coronal sections were cut on a vibratome, mounted, and stained 
with cresyl violet to determine the cannula location and any infusion-related damage. 
Statistical analysis 
Multiple comparisons were made using ANOVA for unpaired data followed by the 
TUKEY post hoc test. For comparison of 2 time points, Student’s unpaired t-test was used. A 






The rodent SCN redox environment is relatively oxidized in early night and relatively 
reduced in late night.  
In this study, biotinylated glutathione ethyl ester, (BioGEE, Invitrogen, Carlsbad CA), was 
used to detect overall protein glutathiolation. BioGEE is a cell-permeable, biotinylated glutathione 
analog that incorporates into free thiol groups of proteins in oxidized environments and is 
unincorporated in reduced environments. Protein thiol groups are highly redox sensitive and can 
serve as an indicator of cellular redox state (Schafer and Buettner; 2001). We examined the relative 
redox states of early (CT 14) and late (CT 19) subjective night in rat SCN by western blot analysis 
to assess the incorporation of BioGEE at each time point. We found a significantly higher level of 
BioGEE incorporation in early night (CT 14, 79.26 ± 10.66 %), indicating a more oxidized state, 
and a lower level of incorporation in late night (CT 19, 34.48 ± 1.04 %), indicating a more reduced 
state (Fig. 2.2, p < 0.01, Student’s t-test, n = 6/CT). These data confirm observations of different 
relative redox states in early and late night in the rat SCN.   
All in vivo experiments were performed in C57BL/6J mice in order to measure wheel-
running behavior. The phase response curves to light stimulus in rats and mice are different in 
shape and mice are known to have lower amplitude phase advances to light. To determine the time 
of the greatest phase advance in late night, we tested three late night time points with light pulses 
(15 min, 100 lux). Light stimulus given during at CT 22 produced the greatest phase advance (0.44 
± 0.05 h), with small delays at CT 20 (-0.03 ± 0.18 h) and CT 24/0 (-0.21 ± 0.31 h) (Fig. 2.3A). 
We also tested two additional light pulse durations at CT 22 to determine the shortest pulse that 
can still elicit a phase advance. A 100 lux light pulse for 15 min and 10 min produced phase shifts 




produced a much shorter phase advance (0.27 ± 0.31 h) (Fig. 2.3B). To verify the CT-relevant 
redox state in early and late night in the mouse SCN, we examined incorporation of BioGEE at 
CT 14 and CT 22. We found a significantly higher level of glutathiolation at CT 14 (82.82 ± 5.83 
%), suggesting a relatively oxidized environment, and lower glutathiolation at CT 22 (62.39 ± 3.95 
%), suggesting a relatively reduced environment (Fig 2.4, p < 0.01, Student’s t-test, n = 9/CT).  
Flipping the redox environment of the SCN from oxidized to reduced blocks the light-
induced phase delay in early night.   
 Injection of the vehicle (aCSF) directly into the SCN followed immediately by a light pulse 
at CT 14 produced a phase delay of 0.86 h. In contrast, injection of 10 mM GSH into the SCN 
followed by a light pulse produced a delay of 0.24 h. Injections of the vehicle and GSH alone 
without an accompanying light pulse had little effect on phasing ( 0.02 h and 0.01 h, respectively, 
Fig. 2.7A, 2.7B). These data support the hypothesis that changing the redox state at CT 14 by 
direct infusion of a reducing agent before a light pulse can block the light-induced phase delay.  
Due to the difficulty of targeting structures as small as a single SCN nucleus, we sometimes missed 
the SCN slightly and hit the third ventricle at the level of the SCN. Injection of GSH into the third 
ventricle near the SCN also blocked the light-induced phase delay. (Fig. 2.7C, 2.7D). However, in 
mice that received injections in the parenchyma far from the SCN, we did not observe a similar 
block of phase delay (Fig. 2.7E, 2.7F).   
In all animals where the injector hit a SCN nucleus (n = 7) or the third ventricle at the level 
of the SCN (n = 4), infusion of vehicle at CT 14 followed by a light pulse produced significant 
phase delays (-0.84 ± 0.11 h) and GSH followed by light pulse resulted in significantly attenuated 
light-induced phase delays in comparison to the vehicle control (-0.16 ± 0.13 h, p < 0.001, n = 11) 




h, respectively) (Fig. 2.8B). In seven animals, the injector missed the SCN and these animals 
constituted a negative control group. In the animals where the injector did not hit the SCN or the 
third ventricle, vehicle followed by a light pulse elicited a delay of -1.01± 0.04 h and GSH followed 
by light pulse did not significantly block the light-induced phase delay (-0.82 ± 0.13 h, p > 0.05, n 
= 7). Vehicle and GSH alone without an accompanying light pulse produced negligible effects (-
0.28 ± 0.15 h and -0.19 ± 0.1 h, respectively) (Fig. 2.8C). Reducing the SCN redox environment 
with GSH did not completely invert the direction of light-induced phase shift from delay to 
advance. Instead, these results suggest that the phase delay induced by a light stimulus at CT 14 
can be blocked by altering the SCN redox state.  
Flipping the redox environment of the SCN from reduced to oxidized does not significantly 
reduce the light-induced phase advance in late night.   
Experiments using the oxidizing agent, DIA, were carried out with the same method as 
with GSH. In animals where the injector hit the SCN or third ventricle at the level of the SCN, 
infusion of vehicle followed by a 100 lux light pulse for 10 min given at CT 22 produced a phase 
advance (0.35 ± 0.07 h). Infusion of 50 mM DIA followed by an identical light pulse at CT 22 
produced a smaller phase advance but was not statistically significantly different from treatment 
with vehicle (0.14 ± 0.07 h). Injections of vehicle or DIA alone produced negligible phase shifts 
of -0.09 ± 0.06 h and 0.06 ± 0.06 h, respectively (p > 0.05, n = 9, Fig. 2.9B). In animals where the 
injector did not reach the SCN or third ventricle, injection of vehicle followed by light pulse at CT 
22 produced a phase advance (0.36 ± 0.09 h) and DIA followed by light pulse produced a similar 
phase advance (0.24 ± 0.16 h). Injections of vehicle or DIA alone produced phase shifts of 0.10 ± 






In this study, we investigate the effects of redox state on the light-induced phase shift of 
wheel-running behavior of an intact mouse. We first verified the differences in redox environment 
during early and late night and found that the SCN is relatively oxidized at CT 14 (early night) and 
relatively reduced at CT 19 (late night) in rats. The endogenous period of mice is shorter than that 
of rats, and mice have a slightly different phase response curve in response to light stimulus 
(Abbott, 2005). We tested three time points in the late night and found that in the experimental 
mice, a light pulse at CT 22 elicits the greatest phase advance.  Comparison of redox environments 
at CT 14 (early night) and CT 22 (late night) in mice shows the SCN at CT 14 is significantly more 
oxidized than at CT 22.  
Using stereotaxic intra-SCN cannulation techniques, we were able to inject redox altering 
chemicals directly into the SCN of live mice and observe its subsequent circadian behavior. Our 
data suggest flipping the SCN redox environment from oxidized to reduced in early night followed 
by a light pulse blocks the light-induced phase delay in circadian rhythms of wheel-running 
activity, while injection of the redox chemical alone has no effect on phase shifting. However, 
changing the SCN redox environment from reduced to oxidized in late night did not conclusively 
block the light-induced phase advance. This is most likely because C57Bl/6 mice are difficult to 
reliably phase advance with light. The mouse phase response curve is usually characterized by a 
large phase delay in the early night and a small phase advance in late night (Comas, 2006). It is 
difficult to observe significant changes in the small light-induced-phase advances because the 
shifts are so close to 0.   
 For some of the experimental mice, the cannula was placed such that the injector hit the 




show that injection of the reducing agent into the third ventricle and near the SCN is sufficient to 
block the light-induced phase delay in activity. This is not entirely surprising, as the lateral walls 
of the third ventricle are made up of the thalamus and hypothalamus and SCN nuclei are positioned 
on either side of the lower lateral walls. There is bidirectional movement of CSF and parenchymal 
interstitial fluid across the ependymal cell layer of the third ventricle (Proescholdt et al., 2000; 
Abbott et al., 2004). This exchange is possible because ependymal cells lack tight junctions, 
facilitating access of diffusible signals to and from the SCN. In fact, due to the difficulty of intra-
SCN cannulations, the SCN is frequently targeted via the third ventricle (Negri et al., 2004, 
Kallingal et al., 2006).  
Earlier work in our lab used the rat hypothalamic brain slice as a model to evaluate the 
effect of redox state on circadian rhythms of neuronal activity. Based on differential effects of 
altering the redox environment on phasing of the neuronal rhythm, the study concluded that the 
SCN redox state is relatively oxidized in early night and relatively reduced in late night. 
Directionality of glutamate-induced phase shifting of neuronal activity rhythms in early and late 
night was found to be determined by the redox environment. Changing the redox environment in 
early night from oxidized to reduced with GSH followed by glutamate stimulation produced a 
phase advance instead of the usual phase delay. Conversely, changing the redox environment in 
late night from reduced to oxidized produced a phase delay rather than a phase advance (Yu, 2007). 
These experiments demonstrate a modulatory role of cellular redox state on the circadian 
clockwork.  
  Yu’s work on the effects of redox environment on neuronal activity rhythms in vivo 
revealed that altering the redox environment from oxidized to reduced or from reduced to oxidized 




vice versa. However, in intact animals, we observed that changing the redox environment from 
oxidized to reduced in early night only blocks the light-induced phase delay, rather than invert it 
into a phase advance. We have multiple possible explanations for this observation. Some studies 
show a phase shift in behavior is smaller than a shift in the SCN neuronal rhythm, suggesting that 
there are extra-SCN factors at play (Vansteensel et al., 2003, Ramkisoensing et al., 2014). Input 
from other brain regions extend into the SCN and contribute to behavior, one such example is the 
lateral geniculate nucleus (LGN). Light reaches the SCN directly from the retina via the 
retinohypothalamic tract and indirectly from the LGN via the geniculo-hypothalamic tract (GHT). 
Activation of either pathway has been shown to produce a phase shift in circadian rhythms. RHT 
activation via optic nerve stimulation produces phase shifts during the night while GHT 
stimulation produces the greatest phase responses during the day (Rusak et al., 1989). Furthermore, 
there is evidence that administration of neuropeptide Y (NPY), a neurotransmitter of the GHT, can 
block glutamate-induced phase shifts during the subjective night and glutamate can block NPY-
induced phase shifts during the subjective day (Biello et al., 1997). The SCN also receives 
serotonergic projections from the raphe nuclei. And similar to NPY, application of serotonin 
during the subjective day results in phase shifting of the circadian rhythm while application of 
serotonin during the subjective night attenuates light-induced phase shifts (Medanic and Gillette, 
1992; Rea et al., 1994). Thus, in an intact animal, the response may be dampened by 
communication with other brain regions that are absent when the SCN is isolated in a brain slice 
preparation.  
 In this study, we demonstrate the ability of redox state to modulate the direction of light-
induced phase shifting in behavioral rhythms. It is possible that RyR is more active in the oxidized 




release of NO leads to a phase delay. When the SCN redox environment is altered to become more 
reduced, RyR becomes less active and sGC becomes activated by NO instead. However, in place 
of the phase advance observed in neuronal firing rhythms, we observed blockage of the light-
induced phase delay in wheel-running activity. These data suggest that while altering SCN redox 
state on its own has no visible effects, it can modulate the animal’s circadian response to light in 
early night. Additionally, time-dependent phase shifting of wheel-running activity may be gated 
by other brain regions. To our knowledge, this is the first demonstration of a direct modulatory 























Figure 2.1 Redox state determines directionality of phase shifting in SCN slices. A. Control, 
peak firing rate occurs at CT7. B. 10 mM microdrop of glutamate applied at CT 14 induced a ~ 3 
h phase delay. C. Pre-incubation in 1 mM GSH prior to glutamate application at CT 14 reversed 
the phase shift to a ~ 3 h phase advance. D. GSH applied alone at CT 14 did not induce a phase 
shift. E. Control, peak firing rate occurs at CT7. F. Application of glutamate at CT 19 induced a ~ 
3 h phase advance. G. Pre-incubation in 0.1 mM DIA prior to glutamate application at CT 19 
reversed the phase shift to a ~ 3 h phase delay. H. DIA applied alone at CT 19 did not cause a 














































Figure 2.2 The rat SCN redox environment is relatively oxidized at CT 14 (early night) and 
relatively reduced at CT 19 (late night). Left: A representative western blot of glutathiolation 
levels using rat SCN slices. CT 14 showed much greater overall protein incorporation of BioGEE 
than CT 19, indicating an oxidized state at CT 14 and reduced state at CT 19. Right: Quantification 
of all blots assayed for BioGEE incorporation. Glutathiolation levels at CT 14 (79.26 ± 10.66 %) 


























































Figure 2.3 A light-induced phase advance can be achieved by 100 lux for 10 min at CT 22.  
A. A 15 min. light pulse of 100 lux elicited an average phase delay of -0.03 ± 0.18 h (n = 3) at CT 
20, an average phase advance of 0.44 ± 0.05 h at CT 22 (n = 3), and an average phase delay of -
0.21 ± 0.31 h at CT 24/0 (n = 3). B. At CT 22, a 100 lux light pulse for 15 min. produced an 
average phase advance of 0.44 ± 0.05 h (n = 3), a 100 lux light pulse for 10 min. produced an 
average phase advance of 0.49 ± 0.17 h (n = 3), and a 100 lux light pulse for 5 min. produced an 


























































Figure 2.4 The mouse SCN redox environment is relatively oxidized at CT 14 (early night) 
and relatively reduced at CT 22 (late night). Left: A representative western blot of 
glutathiolation levels using mouse SCN slices. CT 14 showed greater overall protein incorporation 
of BioGEE than CT 22, indicating a trend of more oxidized state at early night and more reduced 
state at late night. Right: Quantification of all blots assayed for BioGEE incorporation. 
Glutathiolation levels at CT 14 (85.82 ± 5.83 %) and CT 22 (62.39 ± 3.95 %); Student’s t-test, **p 









































Figure 2.5 Validation of intra-SCN localization of cannula. Nissl-stained hypothalamic slice 
















Figure 2.6 Experimental paradigm. Cannulas were surgically implanted at 6 weeks and animals 
were given time to heal before entraining to 12L:12D schedule on running wheels. Animals were 
then placed in D:D (constant darkness) and given a light pulse (20 lux, 5 min) in early or late night. 
4 treatments (aCSF, GSH or DIA alone, aCSF + light pulse, GSH or DIA + light pulse)  were 
administered under dim red light and at least 10 days apart. Animals were given a final light pulse 
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Figure 2.7 Injection of GSH into the SCN or third ventricle blocks the light-induced phase 
delay at CT 14 but GSH injection into the parenchyma of the posterior hypothalamus does 
not block phase delay. Each animal received one light pulse (20 lux, 5 min) and four injections, 
with two followed by a light pulse. All experiments were performed under DD conditions. A. 
Injector track (arrow) accurately hit the SCN. B. Phase shifts measured from actogram. Vehicle 
(aCSF) alone produced a phase delay of -0.02 h, GSH alone (10 mM) produced a delay of -0.01 h, 
vehicle followed by light pulse produced a delay of -0.86 h, and GSH followed by light pulse 
produced a delay of -0.24 h.  C. Injector track (arrow) hit the third ventricle. D. Vehicle alone 
produced a phase delay of -0.36 h, GSH alone produced a delay of -0.33 h, vehicle followed by 
light pulse produced a delay of -0.71, and GSH followed by light pulse produced a delay of -0.09 
h.  Injection of GSH at CT 14 blocked the light-induced phase delay (arrow) E. Injector track 
(arrow) is about 300 µm caudal to the SCN F. Vehicle alone produced a phase delay of -0.19 h, 
GSH alone produced a delay of -0.12 h, vehicle followed by light pulse produced a delay of -1.16 
h, GSH followed by a light pulse produced a delay of -1 h. Injection of GSH followed by light 





















































Figure 2.8 Flipping the redox environment of the SCN from oxidized to reduced blocks the 
light-induced phase delay in early night. A. Actograms of wheel-running behavior in DD 
conditions: each horizontal data set = 24 h. Activity onset is the marker of phase, by convention. 
Treatment of light pulse and/or injection is indicated by yellow arrows. Injection of 10 mM GSH 
diluted in aCSF at CT 14 does not yield a large phase delay (-0.36 h). Injection of vehicle (aCSF) 
at CT 14 did not yield a large phase delay (-0.33 h). Injection of vehicle followed by a light pulse 
(5 min, 20 lux) at CT 14 yielded a large phase delay (-0.71 h). Injection of 10 mM GSH followed 
by a light pulse at CT 14 blocked the phase delay (-0.09 h). B. In animals where the injector hit 
the SCN or the third ventricle, the vehicle or GSH alone produced phase shifts of -0.23 ± 0.08 h 
and -0.14 ± 0.08 h, respectively. Injection of vehicle followed immediately by light pulse (5 min, 
20 lux) at CT 14 produced a phase delay of -0.84 ± 0.11 h. Injection of 10 mM GSH followed by 
a light pulse at CT 14 produced a phase delay of -0.16 ± 0.13 h; One-way ANOVA with Tukey’s 
HSD, ***p < 0.001 **** p < 0.0001, n = 11. C. In animals where the injector missed the SCN and 
third ventricle, vehicle and GSH alone produced phase shifts of -0.28 ± 0.15 h and -0.19 ± 0.1 h, 
respectively. Injection of vehicle followed by light pulse (5 min, 20 lux) produced a phase delay 
of -1.01± 0.04 h and injection of GSH followed by light pulse produces a phase delay of -0.82 ± 
0.13 h; One-way ANOVA with Tukey’s HSD, *p < 0.05 **p < 0.01***p < 0.001, n =7.  
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Figure 2.9 Flipping the redox environment of the SCN from reduced to oxidized does not 
significantly alter the light-induced phase advance in late night. A. Actograms of wheel-
running behavior in DD conditions: each horizontal data set = 24 h. Activity onset is the marker 
of phase, by convention. Treatment of light pulse and/or injection is indicated by yellow arrows. 
Injection of 50 mM DIA diluted in aCSF at CT 22 yields a small phase advance (0.21 h). Injection 
of vehicle (aCSF) at CT 22 produced a small phase delay (-0.07 h). Injection of vehicle followed 
by a light pulse (10 min, 100 lux) at CT 22 yielded a greater phase advance (0.51 h). Injection of 
50 mM DIA followed by a light pulse at CT 22 reduced the phase advance (0.07 h).  B. In animals 
where the injector hit the SCN or the third ventricle, the vehicle or DIA alone produced phase 
shifts of -0.09 ± 0.06 h and 0.06 ± 0.06 h, respectively. Injection of vehicle followed immediately 
by light pulse (10 min, 100 lux) at CT 22 produced a phase advance of 0.35 ± 0.07 h. Injection of 
50 mM DIA followed by a light pulse at CT 22 produced a phase advance of 0.14 ± 0.07 h; One-
way ANOVA with Tukey’s HSD, ***p < 0.001 * p < 0.05, n = 9. C. In animals where the injector 
missed the SCN and third ventricle, vehicle and DIA alone produced phase shifts of 0.10 ± 0.14 h 
and -0.07 ± 0.08 h, respectively. Injection of vehicle followed by light pulse (10 min, 100 lux) 
produced a phase advance of 0.36 ± 0.09 h and injection of DIA followed by light pulse produced 















CIRCADIAN REDOX OSCILLATION IN THE SCN IS DEPENDENT UPON THE DAILY 





 The discovery of a redox oscillation in the SCN is fairly recent. In the SCN, circadian 
rhythmicity is generated and sustained by the molecular feedback loop of core clock genes and the 
daily rhythm in neuronal firing activity. These two arms of the circadian clock are inter-dependent 
and work together to maintain rhythmicity and synchronicity, however, their relationship to the 
redox rhythm remains unclear. Previous work has shown that redox oscillation in the SCN is 
dependent on a functional molecular clock (Wang et al, 2012). Here, we investigate the 
relationship between neuronal firing rhythms and redox environment in the SCN in order to 
evaluate whether the redox oscillation is driven solely by the molecular clock, or also with input 
from neuronal activity. The SCN redox environment is relatively reduced during the day and 
relatively oxidized at night with a large increase in oxidation in early night (CT 14). We found that 
blocking the peak of neuronal firing in midday with tetrodotoxin (TTX) dampens the peak of 
oxidation in early night. This suggests that the redox rhythm may be dependent upon the neuronal 
activity in the SCN. Furthermore, we phase-shifted the neuronal firing rhythm to observe its effect 
on the redox oscillation. We found that a phase advance of 6.5 h in neuronal activity peak resulted 









Circadian metabolic and redox oscillations have been reported in numerous tissue types, 
including non-neuronal cells, such as red blood cells, liver, and cultured fibroblasts (O’Neill and 
Reddy, 2011; Edgar et al., 2012; Putker et al., 2017). The SCN also exhibits circadian redox 
rhythms but differs from the other tissues and brain regions as it undergoes daily cycles of 
synchronized intrinsic neuronal firing. The SCN is made up of approximately 20,000 neurons, 
each with its own cell-autonomous clock. In dissociated cultures, recordings of neuronal firing and 
luciferase-based reporters of Per1 and Per2 expression show these neurons exhibit independent 
rhythms of firing and gene expression. In the intact SCN, these rhythms are synchronized, self-
sustained, and have an endogenous period of approximately 24 h (Welsh et al., 2010).  SCN 
neurons can fire action potentials in the absence of synaptic input and single-unit recording 
experiments reveal a spontaneous peak in electrical activity during the animal’s subjective day. It 
is estimated that during this time, individual neurons are active for 4-6 h and then are relatively 
electrically silent in the subjective night (Brown and Piggins, 2009). It is unknown if, and how, 
this daily cycle of activity contributes to the overall SCN redox oscillation.  
The functional roles of SCN neuronal activity rhythms have been explored in numerous 
studies utilizing tetrodotoxin (TTX), a selective and reversible Na+ channel blocker that can be 
used to inhibit the generation of action potentials and block synaptic communication. In addition 
to the inhibition of electrical activity, application of TTX can abolish rhythms in behavior, peptide 
secretion, and SCN glucose utilization. Strikingly, after TTX wash-out, all rhythms returned in 
phase with the oscillation before treatment (Schwartz et al., 1987; Earnest et al., 1991; Shibata and 
Moore, 1993). These studies seem to suggest that TTX abolishes circadian output rhythms but 




reporter gene (PER1::LUC) and mPer1–driven green fluorescent protein (PER1::GFP) in the SCN 
under TTX treatment show significant dampening of amplitude and eventual loss of synchrony 
after many days. Upon washout, amplitude of gene expression is restored in the same temporal 
phase as the prior oscillation (Yamaguchi et al., 2003, Maywood et al., 2007). Protein expression 
was also suppressed by TTX treatment, with PER1 and PER2 immunoreactivities significantly 
lowered at their expected peak (Yamaguchi et al., 2003). It is possible that disruption of 
intercellular coupling reduces clock gene expression and synchronization. 
 Brain energy metabolism and activity levels are intimately linked. The rate of glucose 
utilization can be used to reflect overall activity. In a series of studies measuring 14C-labeled 2-
deoxyglucose uptake, Schwartz et al. showed that even in the absence of light, glucose 
consumption in the SCN exhibits circadian rhythmicity with higher uptake in the subjective day 
and lower uptake in the subjective night (Schwartz and Gainer, 1977; Schwartz et al., 1980). It is 
possible that this observation may be related to the sodium-potassium pump (Na+/K+-ATPase), 
whose activity is necessary for maintenance of the resting membrane potential after firing. In the 
SCN, the Na+/K+-ATPase is more active during the day than during the night and the activity of 
this energetically costly pump could contribute to the rhythmic uptake of glucose (Wang et al., 
2012). Furthermore, evaluation of ATP usage in the brain shows that electrical signaling and 
synaptic activity are the main consumers of energy (Harris et al., 2012). Thus, high levels of 
glucose consumption correspond to high levels of neuronal activity during the subjective day.  
The SCN exhibits daily cycles in neuronal activity and glucose consumption, therefore, it 
is not surprising that it also exhibits daily rhythms in redox state. Changes in levels of reduced 
metabolic cofactors such as nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine 




2015). One glucose molecule yields multiple molecules of NADH (via glycolysis) and NADPH 
(via the pentose phosphate pathway). NADPH is a key component in the cellular antioxidant 
system and is necessary for the regeneration of important antioxidants such as glutathione (GSH). 
It is possible that activity-dependent ATP usage can reduce NADH levels and a rise in reactive 
oxygen species (ROS) from subsequent ATP production can deplete cellular NADPH.  
 In this study, we examine the effects of blocking Na+-dependent action potentials with TTX 
on redox oscillation in the SCN. Redox state in the SCN is relatively reduced in the subjective day 
and oxidized in the subjective night, with a peak in oxidation at CT 14 (Wang et al., 2012). 
Considering the direct influence cellular activity has on metabolism and redox balance, we 
hypothesize that acute inhibition of neuronal electrical and synaptic activity during the subjective 
day will have an immediate impact on the redox oscillation. Early work done in our lab showed 
that treating SCN slices with cyclic guanosine monophosphate (cGMP) at CT 18 reliably advances 
the peak in neuronal firing rhythms by 6 h (Prosser et al., 1989). To further probe the relationship 
between the SCN neuronal firing rhythm and redox rhythms, we phase-shift the peak of neuronal 
activity with cGMP to observe its effect on the peak of oxidation of the redox oscillation. We 
hypothesize the redox rhythm will shift with the neuronal activity rhythm (Fig. 3.3).   
 
MATERIALS AND METHODS 
 
Animals 
Male and female Long Evans/BluGill rats between 8-16 weeks of age were used for this 
study. Breeding colonies were generated and maintained at the University of Illinois at Urbana-




schedule and given food and water ad libitum. All animal procedures were approved by the UIUC 
Institutional Animal Care and Use Committee.  
Tissue collection and TTX treatments  
Animals were sacrificed during the day. 500 µm-thick coronal hypothalamic brain slices 
containing the SCN were made on a mechanical tissue chopper and the SCN were isolated with a 
2 mm diameter tissue punch. The SCN slices were maintained in a tissue chamber perfused with 
EBSS saturated with 95% O2/5% CO2 at 37°C. A concentration of 0.5 µM TTX has been widely 
used to successfully inhibit neuronal firing in the SCN (Guilding et al., 2009). Tissue slices were 
perfused with control EBSS or 0.5 µM TTX in EBSS at CT 6 and collected at CT 9/10 or CT 14 
after incubation in BioGEE (Invitrogen, Carlsbad CA) to determine glutathiolation levels (Fig. 
3.1).  
Tissue collection and cGMP treatments  
Animals were sacrificed at ZT 10. 500 µm-thick coronal hypothalamic brain slices 
containing the SCN were made on a mechanical tissue chopper and the SCN were isolated with a 
2 mm diameter tissue punch. SCN slices were maintained in a tissue chamber perfused with EBSS 
saturated with 95% O2/5% CO2 at 37°C. SCN slices were treated with 0.5 µM 8-bromogruanosine 
3’, 5’-cyclic monophosphate (8-Br-cGMP, Sigma-Aldrich, St. Louis MO), a water-soluble and 
cell-permeable cGMP analog, in a standing bath of oxygenated EBSS at CT 18 for 1 h (optimal 
concentration and treatment time as determined by Prosser et al. 1989). Slices were collected every 
4 h on the following day after incubation with BioGEE. To ensure the redox rhythm was sustained 







At the appropriate CT times, SCN tissue slices were incubated with 250 µM biotinylated 
glutathione ethyl ester (BioGEE, Invitrogen, Carlsbad CA) for 1 h before collection. Samples were 
collected immediately post-treatment, flash-frozen on dry ice, and stored at -80°C until processing. 
Each frozen sample was mixed with 50 µL RIPA buffer for rat SCN and 30 µL RIPA buffer for 
mouse SCN (50 mM Tris pH 7.5, 150 mM NaCl, 1mM EDTA, 0.2% SDS, 1% NP-40, 0.5% 
sodium deoxycholate) with 1X cOmplete protease inhibitor cocktail (Roche, Basel SUI) on ice 
and mechanically homogenized. After 2 min incubation on ice, samples were centrifuged at 14,000 
RPM and the supernatant is transferred to a clean tube. Protein concentration was determined by 
BCA protein assay (Pierce, Rockford IL). Total protein (25 µg/sample) was resolved in 8% SDS-
PAGE and transferred to nitrocellulose membrane (Bio-Rad, Hercules CA). Membranes were 
probed with 1:2000 mouse anti-biotin peroxidase antibody (Cellsignaling, Danvers MA) overnight 
and developed with SuperSignal chemiluminescent substrate (Pierce, Rockford IL). Blots were 
stripped with Restore Western Blot Stripping Buffer (Thermofisher, Rockford IL) and re-probed 
with anti-a-tubulin antibody (Cellsignaling, Danvers MA). Level of BioGEE incorporation was 
determined by the ratio of overall biotin intensity over the band intensity of tubulin and normalized 
to the maximum value of the same blot. 
Statistical analysis 
Multiple comparisons were made using ANOVA for unpaired data followed by the 








Inhibition of SCN neuronal activity in subjective day affects redox state  
 
To elucidate the role of daytime neuronal firing in the rise in oxidation at CT 14, we used 
TTX to inhibit the generation of Na+-dependent action potentials in the subjective day. SCN slices 
were maintained in chambers and perfused with either control EBSS or 0.5 µM TTX in EBSS at 
CT 6. Treated and untreated slices were collected and evaluated for the capacity to incorporate 
BioGEE (glutathiolation) at CT 9/10 and at CT 14. Untreated SCN slices were relatively reduced 
at CT 9/10 (71.72 ± 3.32 %) and significantly more oxidized at CT 14 (96.15 ± 2.63 %) (Fig. 3.2, 
p < 0.01, One-way ANOVA, n = 4-7/CT). However, SCN slices treated with TTX from CT 6 were 
reduced at CT 9/10 (71.65 ± 4.83 %) but less oxidized at CT 14 (80.58 ± 3.74 %) (Fig. 3.2 p > 
0.05, One-way ANOVA, n = 4-7/CT). These results suggest that inhibiting Na+-dependent 
neuronal activity in the SCN from CT 6 can block the peak in oxidation at CT 14 of the redox 
oscillation.  
SCN redox rhythm remains stable for at least 2 days in vitro  
 cGMP induces phase shifts in the oscillation of SCN electrical activity in the subjective 
night. Prosser et al. determined cGMP produces the greatest phase advance (6 h) when applied at 
CT 18 (Prosser et al., 1989). To treat the SCN explants with cGMP and collect at appropriate time 
points the following day, slices were kept in tissue chambers for up to 48 h. To ensure SCN slices 
maintained a reliable redox rhythm, control slices were incubated with EBSS at CT 18 for 1 h. 
Samples were incubated with BioGEE and collected on the following day at CT 6, CT 10, CT 14, 
CT 18, and CT 22. We found that glutathiolation was highest at CT 14 (87.46 ± 4.31 %) and lowest 




6 (Fig. 3.4, p < 0.05, One-way ANOVA, n = 7-9/CT). These data show that SCN redox rhythm is 
maintained with a peak in oxidation at CT 14.  
Peak in oxidation is delayed rather than advanced in SCN treated with cGMP 
 Treatment with cGMP at CT 18 produces a phase advance in peak of SCN neuronal firing 
of about 6 h. We had expected the redox rhythm to advance as well and assessed glutathiolation 
every 4 h from CT 2 to CT 18 in slices treated with cGMP the day before. Unexpectedly, the peak 
in oxidation shifted backwards with glutathiolation highest at CT 18 (88.65 ± 6.30 %) and lowest 
at CT 2 (49.32 ± 6.65 %) (Fig. 3.5, p < 0.01, One-way ANOVA, n = 6-8/CT). Because CT 22 was 
not included, the experiment was repeated to include CT 10 to CT 22. We found that the highest 
peak in glutathiolation delayed further to CT 22 (75.84 ± 8.56 %) while the lowest level of 
glutathiolation was at CT 10 (55.42 ± 4.42 %) (Fig. 3.6, p > 0.05, One-way ANOVA, n = 4-6/CT). 
Unexpectedly, these results suggest the SCN redox rhythm represented by the peak in oxidation 
shifted back from CT 14 to CT 22 while the peak in neuronal activity rhythm is shifted forward 




In the SCN, there are two main oscillatory arms of the circadian clockwork: the molecular 
oscillation of clock genes and the daily rhythm of neuronal activity. The discovery of a novel redox 
oscillation in the SCN that is dependent on a functional molecular clock and can modulate neuronal 
excitability brings forth questions about the nature of this rhythm. Cellular redox regulation is 
dynamic. Overall redox state is not static but, although tightly controlled, changes as a function of 
metabolic processes.  In the SCN, the phase of redox oscillation corresponds to neuronal activity 




during the middle of the subjective day, whereas the redox environment is reduced during this time 
but then becomes most oxidized in early night (Schwartz et al., 1980, Green and Gillette 1982; 
Wang et al, 2012). The timing of these events suggests that glucose utilization increases to meet 
the metabolic demands of reestablishing ionic gradients in activated cells. Here, we investigate the 
relationship between neuronal activity in the SCN and the redox oscillation. 
TTX is frequently used to abolish neuronal activity in the SCN. It selectively and reversibly 
blocks voltage-dependent Na+ channels, inhibiting the generation of action potentials without 
affecting resting membrane potential. We perfused SCN slices with TTX from CT 6 to the time of 
collection in order to block Na+-dependent neuronal firing that peaks at CT 7. We evaluated 
glutathiolation at CT 9/10 and CT 14 of SCN slices perfused with and without TTX and found that 
SCN tissue in which daytime neuronal activity is blocked by TTX did not exhibit the increase in 
oxidation at CT 14 as compared to SCN tissue perfused with control media. These data suggest 
that neuronal firing rhythms and synaptic activity of the SCN have a direct effect on the nighttime 
redox environment. This is supported by the finding that inhibition of Na+-dependent action 
potentials with TTX during the day significantly dampened glucose utilization in vitro from CT 6 
to CT 12, when neuronal activity is high, and did not significantly affect glucose utilization 
between CT 18 and CT 23, when neuronal activity is typically low (Newman, 1992). Curiously, 
TTX application did not affect glucose utilization at CT 3, indicating that there may be some kind 
of metabolic activity at CT 3 that continues even in the absence of Na+-dependent action potentials.  
However, lower levels of overall activity decrease energetic demands during the day and a decline 
in ATP synthesis and subsequent ROS generation could account for the lack of increased oxidation 




To further investigate the impact of SCN electrical rhythms on redox state, we phase-
advanced the peak in neuronal firing to observe its effect on the redox rhythm. Signaling via the 
cGMP pathway is necessary for light-induced phase advance in the late subjective night (Prosser 
et al., 1989; Tischkau et al., 2003). Prosser et al. reported application of a cGMP analog to SCN 
slices maintained in chambers in late night induces reliable and robust resetting of the electrical 
rhythm. They determined that the degree of phase shifting is time-of-day dependent and treatment 
at CT 18 results in the maximum advance of peak in neuronal firing that is sustained for at least 2 
days in vitro (Prosser et al., 1989).  
In our experiments, cGMP was applied at CT 18 to induce a 6 h advance. Evaluation of 
redox state following control treatment with EBSS showed the SCN slices kept in chambers for 
up to 48 h maintained a stable redox rhythm with a peak in oxidation at CT 14 on the following 
day (Fig. 3.4). Treatment with 0.5 µM of a cGMP analog resulted in a shift of the peak in oxidation 
to CT 18 and CT 22 (Fig. 3.5). We had expected the redox rhythm to advance with neuronal firing 
due to the metabolic consequences of high activity levels, however, it appears that the rhythm 
shifted in the other direction. It is also possible that the peak in oxidation advanced to CT 18 and 
CT 22 in the previous cycle and our measurements reflect the rhythm in the second cycle. There 
are multiple possible explanations for these results as the mechanisms for generation of circadian 
redox rhythms are poorly understood and the relationship between redox and core timekeeping 
elements are still being explored.  
Reactive oxygen species are important contributors to the overall redox environment. They 
are generated in normal metabolic functions and accumulate if antioxidant defenses are 
overwhelmed or deficient. Superoxide dismutases (SODs) are important enzymes in the 




conversion of superoxide (O2-) radical to oxygen (O2) and hydrogen peroxide (H2O2) (Buettner, 
2011). Several studies have demonstrated that SOD expression and activity display circadian 
variation in several rodent tissues, including brain (Diaz-Munoz et al., 1985; Hodoglugil et al., 
1995; Martin et al., 2003; Jang et al, 2011). Additionally, SOD1 mRNA is dampened and SOD1 
protein expression rhythm is phase-shifted in the liver of PER2 knockout mice, while both mRNA 
and protein rhythms are phase-shifted in PER1 and PER2 double knockout mice (Jang et al., 2011). 
These data provide evidence for regulation of SOD by core circadian mechanisms. Thus, cGMP-
mediated induction of core clock genes such as Per1 and Per2 could contribute to the phase shift 
in redox state. In these experiments, changes in redox state as a response to cellular metabolic 
activity cannot be separated from the complexities of circadian regulation of the antioxidant 
system.  
The increase in levels of BioGEE incorporation and thus oxidation level coincides with 
SCN tissue that have been in the perfusion chamber for the longest amount of time, approaching 
48 h. There is a possibility that the increase in oxidation at these time points can be attributed to 
mounting oxidative stress. However, control experiments performed with EBSS alone showed 
only a peak in oxidation at CT 14, reflecting normal SCN redox rhythm. Additionally, CT 6 and 
CT 22 showed comparable levels of BioGEE incorporation (Fig. 3.4). SCN tissue in these control 
experiments have been in chambers for the exact same amount of time under identical conditions, 
suggesting that the increase in oxidation is unlikely to be due solely to oxidative stress.  
Taken together, these data suggest SCN neuronal firing rhythms have a direct impact on 
the redox rhythm. The inhibition of the peak in electrical activity in midday significantly dampened 
the peak in SCN oxidation at CT 14. Furthermore, shifting the neuronal electrical rhythm appears 




unknowns, it is difficult to predict the timescale and direction of the redox phase shift in response 
to changes in neuronal activity. These experiments are limited because they can only provide 
insight into the redox oscillation for a limited timeframe. Real-time redox imaging experiments 






























Figure 3.1 The rat SCN is most oxidized at CT 14. The rat SCN is reduced during the subjective 
day and oxidized during the subjective night, with a peak in oxidation levels at CT 14. SCN tissue 
punches were perfused with control EBSS or 0.5 µM TTX in EBSS at CT 6 and collected at CT 
9/10 or CT 14 before incubation in BioGEE to determine glutathiolation levels. Red lines represent 


































Figure 3.2 Blocking peak of spontaneous neuronal firing at CT 7 with TTX dampened the 
increase in glutathiolation at CT 14. Left: A representative western blot of glutathionlation levels 
using rat SCN slices. At CT 14, SCN slices incubated with TTX in EBSS from CT 6 to CT 14 
showed singificantly less BioGEE incorporation than SCN slices incubated with control EBSS.  
Right: Quanitification of all blots assayed for BioGEE incorporation. Glutathiolation levels are 
71.72 ± 3.32 % for CT 9/10 Untreated, 71.65 ± 4.83 % for CT 9/10 TTX, 96.15 ± 2.63 % for CT 
14 Untreated, and 80.58 ± 3.74 % for CT 14 TTX; One-way ANOVA with Tukey’s HSD, *p < 
0.05 **p < 0.01, n = 4-7/CT.  
 














































































Figure 3.3 Treatment with cGMP from CT 18 – CT 19 produces a 6 h phase advance. SCN 
neuronal firing usually occurs around CT 7 (top panel). Incubation with 0.5 µM cGMP at CT 18 
for 1 h (vertical bar, bottom panel) produces a phase advance of about 6 h with new peak of 
neuronal firing around CT 24/0 - CT 1. We will evaluate glutathiolation at various CT times to 
determine if the peak in oxidation (blue line) changes with the shift in peak neuronal firing 
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Figure 3.4 SCN redox rhythm remains stable for at least 2 days in chambers perfused with 
EBSS.	Left: A representative western blot of glutathionlation levels at CT 6, 10, 14, 18, 22 of rat 
SCN slices treated with EBSS at CT 18 of the previous day. BioGEE incorporation is highest at 
CT 14 and lowest at CT 6. Right: Quanitification of all blots assayed for BioGEE incorporation. 
Glutathiolation levels are 62.99 ± 6.33 % at CT 6, 73.72 ± 6.28 % at CT 10, 87.46 ± 4.31 % at 
CT 14, 73.26 ± 4.99 % at CT 18, and 67.29 ± 7.23 % at CT 22. One-way ANOVA with Tukey’s 









































Figure 3.5 Peak in oxidation of cGMP-treated SCN tissue occurs at CT 18. Left: A 
representative western blot of glutathionlation levels at CT 2, 6, 10, 14, 18 of rat SCN slices treated 
with 0.5 µM of a cGMP at CT 18 of the previous day. BioGEE incorporation is highest at CT 18 
and lowest at CT 2. Right: Quanitification of all blots assayed for BioGEE incorporation. 
Glutathiolation levels are 49.32 ± 6.65 % at CT 2, 60.01 ± 3.42 % at CT 6, 57.13 ± 8.81 % at CT 
10, 63.15 ± 5.04 % at CT 14, and 88.65 ± 6.30 % at CT 18. One-way ANOVA with Tukey’s HSD, 
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Figure 3.6 Oxidation level of cGMP-treated SCN tissue is further increased at CT22. Left: A 
representative western blot of glutathionlation levels at CT 10, 14, 18, 22 of rat SCN slices treated 
with 0.5 µM of a cGMP at CT 18 of the previous day. BioGEE incorporation is highest at CT 22 
and lowest at CT 10. Right: Quanitification of all blots assayed for BioGEE incorporation. 
Glutathiolation levels are 55.42 ± 4.42 % at CT 10, 56.83 ± 5.33 at CT 14, 69.26 ± 8.33 % at CT 















































CHAPTER FOUR  
THE HIPPOCAMPUS EXHIBITS A CIRCADIAN REDOX OSCILLATION AND RHYTHM 




 We previously reported a novel redox oscillation in the suprachiasmatic nucleus (SCN) 
that is dependent upon the molecular clock and is capable of modulating neuronal excitability 
(Wang et al., 2012). Here, we focus on the hippocampus where clock gene expression undergoes 
a circadian oscillation anti-phase to that of the SCN.  Using long-term redox imaging and 
evaluation of glutathiolation, we found an oscillation of redox state with a period near 24 h in the 
hippocampus that is also 180° out-of-phase to the redox oscillation of the SCN. We then evaluated 
neuronal excitability of CA1 neurons at various times of day and observed a rhythm in resting 
membrane potential that is circadian time (CT) dependent and opposite from that of the SCN. 
Application of glutathione (GSH), a reducing agent, rapidly depolarized the resting membrane 
potential of CA1 neurons; the magnitude of this change is CT time dependent and again, opposite 
from the SCN. These findings extend potential redox mechanisms of circadian timekeeping from 
the SCN to the hippocampus. Insights into this system could be useful in understanding circadian-









† Parts of this chapter appear in Kouzehgarani GN, Bothwell MY et al., Circadian rhythm of 
redox state regulates membrane excitability in hippocampal CA1 neurons. European Journal of 







The circadian clock is organized hierarchically. Peripheral oscillators with tissue-specific 
clock gene expression and functions are synchronized by the suprachiasmatic nucleus (SCN), 
which serves as the master oscillator. Several extra-SCN oscillators have been identified in the 
central nervous system. Robust rhythms in core clock gene expression and electrical activity are 
observed in a number of structures, such as other hypothalamic nuclei, the olfactory bulb, 
amygdala, cerebellum, cerebral cortex, and hippocampus (Abe et al., 2002; Granados-Fuentes et 
al., 2004, Guilding and Piggins 2007). These areas differ in phase, ability to sustain rhythmicity, 
and their relationship to the SCN. Rhythmic Per1 and Per2 expression has been found in the 
dentate gyrus as well as the CA1, CA2, CA3, and dentate gyrus regions of the hippocampus 
(Wakamatsu et al., 2001; Feillet et al., 2008; Wang et al., 2009). Strikingly, hippocampal clock 
gene rhythms are completely anti-phase to SCN clock gene rhythms (Wang et al., 2009). The 
hippocampus is of particular interest to our lab due to its importance in learning and memory, its 
susceptibility to oxidative stress, and the accumulating evidence that hippocampal function 
displays circadian rhythmicity.  
In the 1970’s, a landmark study showed that memory retention for associative learning 
oscillates in a circadian manner. Rats tested for avoidance conditioning showed that high and low 
retention alternated every 12 h, with maximum retention every 24 h post training (Holloway and 
Wansley, 1973). This alternating pattern was not present in SCN-lesioned animals with severely 
disrupted circadian rhythms, suggesting involvement of the circadian system (Stephan and 
Kovacevic, 1978).  Since then, numerous other studies in rats and humans have shown that phase 
shifts and disturbances in circadian rhythmicity interfere with hippocampus-dependent memory 




Long-term potentiation (LTP) is a critical component of memory formation in which 
synaptic connections undergo activity-dependent changes in synaptic strength. Some studies have 
reported day/night rhythms in LTP in the rodent hippocampus with LTP of greater magnitude in 
the nighttime (Harris and Teyler, 1983; Chaudhury and Colwell, 2002). These studies were 
performed in trimmed slices in the absence of extra-hippocampal input and maintained diurnal 
variations in 12 h of light followed by 12 h of dark as well as in constant darkness and was 
independent of the time of sacrifice (Chaudhury et al., 2005). This data provides evidence for 
rhythmic modulation of synaptic plasticity in the hippocampus under free-running conditions, 
suggesting that it may be endogenously circadian.  
The cAMP/mitogen-activated protein kinase (MAPK)/cAMP Response Element Binding 
Protein (CREB) signaling pathways are required for induction of LTP and memory consolidation 
in the hippocampus (Eickel-Mahan and Storm, 2009; Kandel, 2012). MAPK and CREB 
phosphorylation, as well as cAMP levels, have been found to undergo circadian oscillation in the 
hippocampus and appear to be dependent upon Ca2+-stimulated adenylyl cyclase activity (Eickel-
Mahan et al., 2008). In the SCN, activation of the MAPK pathway and CREB-mediated gene 
transcription is responsive to light and can subsequently phase shift circadian clock rhythms 
(Butcher et al., 2002). Brain-derived neurotrophic factor (BDNF) is a key neurotrophin involved 
in activity-dependent synaptic plasticity and there is evidence that its expression displays diurnal 
variations in the hippocampus (Schaaf et al., 2000; Yamada and Nabeshima, 2003). In the SCN, 
BDNF is rhythmically expressed and has been implicated in circadian regulation.  Interestingly, 
the same pathways and proteins that modulate hippocampal plasticity are also necessary for 




It is possible that the pathways of memory consolidation may be activated repeatedly to be 
most effective. The presence of shared diurnal variations in the hippocampus and SCN as well as 
the many studies implicating circadian rhythmicity in memory formation suggest that there may 
be other shared links. We hypothesized that extra-SCN brain regions, such as the hippocampus, 
may exhibit diurnal oscillations in redox state.  In this study, we report that the rat hippocampus 
has a redox oscillation of near 24 h and is anti-phase to that of the SCN. We also provide evidence 
that, like the SCN, the hippocampus exhibits circadian variability in membrane excitability and 
redox state could play a role in the regulation of neuronal excitability in hippocampal CA1 neurons.  
 
MATERIALS AND METHODS 
Animals 
Long Evans/BluGill rats between 8-16 weeks of age were used for this study. Breeding 
colonies were generated and maintained at the University of Illinois at Urbana-Champaign. 
Animals were housed under standard conditions on a 12 h light and 12 h dark (LD) schedule and 
given food and water ad libitum. All animal procedures were approved by the UIUC Institutional 
Animal Care and Use Committee.  
Brain slice preparation for imaging 
Hippocampal brain slice cultures were prepared from 2-3 wk-old rats, sacrificed 
unanesthetized between ZT 6-9 (ZT 0 = lights on). The brain was quickly removed and 
immediately placed into an ice-cold slicing solution (KCl 2.5 mM, MgSO4 10.0 mM, CaCl2 0.5 
mM, NaH2PO4 1.2 mM, glucose 11.0 mM, sucrose 234.0 mM, NaHCO3 26.2 mM, pH 7.2-7.4, 
290-300 mOsm/L) saturated with 95% O2/5% CO2. A 350 µm-thick coronal hippocampal slice 




culture insert (Millipore, Billerica MA) with DMEM (Gibco, Carlsbad CA) containing 0.5% B-27 
supplement, 1.0 mM glutamine, and 25 µg/ml penicillin/streptomycin at 37°C. Slices were fed the 
next day and imaged after 2 days in culture.  
Real-time redox imaging  
A hippocampal slice cultured for 2 days was transferred to a 37°C chamber on the 
microscope stage and perfused continuously with Earle’s Essential Balanced Salt Solution (EBSS) 
without phenol red (NaCl 116.4 mM, KCl 5.4 mM, CaCl2 1.8 mM, MgSO4 0.8 mM, NaH2PO4 1.0 
mM, glucose 24.5 mM, 26.2 mM, gentamicin 1 mg/L, pH 7.2-7.4, 290-300 mOsm/L) saturated 
with 95% O2/5% CO2. Two-photon microscopy was performed with the Zeiss LSM 510 confocal 
laser-scanning microscope with MaiTai laser on a 20X 0.8 NA objective (Carl Zeiss, Obercochen 
DE). Excitation wavelength was set to 730 nm and two channels of emission at 430-500 nm and 
500-550 nm are recorded simultaneously (Georgakoudi and Quinn, 2012).  Imaging sessions began 
at CT 9-11 with a sampling rate of 4 sec/frame at 365 sec intervals for 720 frames (72 h total).  
Florescence intensity of at 400+ (NAD(P)H) and 500+ nm (FAD) for each frame was acquired by 
Zeiss LSM software. Relative redox state was calculated from the ratio of fluorescence at 500+ 
nm over 400+ nm (F500+/F400+).  
Glutathiolation assay 
500 µm-thick coronal brain slices containing the hippocampus were made on a mechanical 
tissue chopper and the hippocampus isolated with a scalpel. The brain slices were maintained in a 
tissue chamber perfused with EBSS saturated with 95% O2/5% CO2 at 37°C. Tissue slices were 
incubated with 250 µM biotinylated glutathione ethyl ester (BioGEE, Invitrogen, Carlsbad CA) 
for 1 h before collection. Samples were collected immediately post-treatment, flash-frozen on dry 




(50 mM Tris pH 7.5, 150 mM NaCl, 1mM EDTA, 0.2% SDS, 1% NP-40, 0.5% sodium 
deoxycholate) with 1X cOmplete protease inhibitor cocktail (Roche, Basel SUI) on ice and 
mechanically homogenized. After 2 min incubation on ice, samples were centrifuged at 14,000 
RPM and the supernatant transferred to a clean tube. Protein concentration was determined by 
BCA protein assay (Pierce, Rockford IL). Total protein (25 µg/sample) was resolved in 8% SDS-
PAGE and transferred to nitrocellulose membrane (Bio-Rad, Hercules CA). Membranes were 
probed with 1:2000 mouse anti-biotin peroxidase antibody (Cellsignaling, Danvers MA) overnight 
and developed with SuperSignal chemiluminescent substrate (Pierce, Rockford IL). Blots were 
stripped with Restore Western Blot Stripping Buffer (Thermofisher, Rockford IL) and re-probed 
with anti-a-tubulin antibody (Cellsignaling, Danvers MA). Level of BioGEE incorporation was 
determined by the ratio of overall biotin intensity over the band intensity of tubulin and normalized 
to the maximum value of the same blot.  
Immunohistochemistry 
Coronal hippocampal slices of 500 µm were made on a mechanical tissue chopper and 
isolated with a scalpel. The brain slices were maintained in a tissue chamber perfused with EBSS 
saturated with 95% O2/5% CO2 at 37°C. Tissue slices were incubated with 250 µM biotinylated 
glutathione ethyl ester (BioGEE, Invitrogen, Carlsbad CA) for 1 h before collection and fixed in 
4% paraformaldehyde for 2 h. 20 µm slices were made on the cryostat and mounted on glass slides. 
Slices were pre-treated with 1% H2O2 in PBS for 30 min, followed by incubation with ABC-HRP 
reagent (Vector Labs, Burlingame CA) for 1 h and developed in DAB (Vector Labs, Burlingame 
CA) for 20 min. Controls for endogenous biotin consisted of hippocampal slices not incubated 






Multiple comparisons were made using ANOVA for unpaired data followed by the 
TUKEY post hoc test. A probability of p < 0.05 was considered significant. For analysis of real-
time redox imaging, X2 periodogram was performed with a MATLAB toolbox, Clocklab 
(Actimetrics, Wilmette IL), to determine the length of circadian period (t). X2 values were 
calculated from recording data and t was determined from the highest value above confidence 
interval of 0.001. 
 
RESULTS 
There is an endogenous oscillation of redox state in the rat hippocampus   
Using real-time ratiometric redox imaging of auto-fluorescent metabolic cofactors FAD 
and NAD(P)H, we found a near-24 h oscillation of redox state in the CA1 region of the rat 
hippocampus. The coronal hippocampal slice was first cultured for two days, then imaged for three 
days and the redox oscillation persisted throughout all three days of imaging. c2 periodogram 
analysis revealed a period (t) of 22.75 h (Fig. 4.1)  
Redox rhythm of the hippocampus is anti-phase to the redox rhythm of the SCN  
Given that real-time redox imaging does not accurately predict phase and to assess time-
of-day changes in redox state of the hippocampus, we evaluated the capacity to incorporate 
biotinylated reduced glutathione (BioGEE) in the hippocampus every four hours. We found that 
glutathiolation was highest between CT 6 and CT 10 (84.74 ± 8.9 % and 90.15 ± 4.57 %, 
respectively), indicating a relatively oxidized state, and lowest at CT 14 (28.06 ± 3.6 %), indicating 
a relatively reduced state (Fig. 4.2A, 4.2D, p < 0.001, One-way ANOVA, n = 4/CT). In both 




ascorbic acid (AA) ratio performed by Wang et al., CT 7 was found to be most reduced whereas 
CT 14 was found to be most oxidized in the SCN (Fig. 4.2B, 4.2C). Thus, it appears that the 
hippocampus and SCN are in opposite relative redox states during midday (CT 6-10) and early 
night (CT 14). This suggests that the redox rhythm in these two regions are anti-phase. To better 
visualize the relative redox states of the hippocampus and SCN, we obtained hippocampal and 
SCN tissue from the same animal and visualized BioGEE incorporation with an anti-biotin 
antibody in midday (CT 6) and early night (CT 14). The differences are striking, with BioGEE 
incorporation low in the SCN at CT 6 while high in the hippocampus at CT 6 and high at CT 14 
in the SCN while low in the hippocampus at CT 14 (Fig 4.3A, 4.3B, n = 3/CT).  
Electrophysiological properties of hippocampal CA1 neurons show circadian variations 
antiphase to the SCN 
To investigate the relationship between the SCN redox rhythm and neuronal membrane 
excitability, Wang et al. used whole-cell patch-clamp recording to measure resting membrane 
potential (Vm) from current-clamped neurons. They observed circadian oscillations of Vm in the 
SCN, with neurons more depolarized in the subjective day (CT 7) and hyperpolarized in the 
subjective night (CT 14) (Fig. 4.4A). We evaluated Vm of CA1 neurons at various times of day 
and observed that resting membrane potential was hyperpolarized during the subjective day (-
75.98 ± 1.77 mV, CT 7) and depolarized during the subjective night (-68.84 ± 0.64 mV, CT 14), 
opposite to that of the SCN (Fig. 4.4B, p < 0.01, One-way ANOVA, n = 8-19/CT)‡. In the SCN, 
Wang et al. found that exposure to 1 mM of the reducing agent glutathione (GSH) resulted in brief 
depolarization. They observed the maximal depolarization effects around CT 10-12, during the 
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transition from subjective day to night (Fig. 4.4C). We applied 1mM GSH for 5 min to the CA1 
region of the hippocampus and the neurons produced rapid membrane depolarization with average 
magnitude lowest at the transition from subjective day to night (CT 10-12) (Fig. 4.4D, p < 0.01, 
One-way ANOVA, n = 4-11/CT). Average GSH-induced depolarizations of Vm in the SCN and 
hippocampal CA1 neurons appear to be CT-dependent and show opposite trends.  
 
DISCUSSION 
The SCN is connected to brain regions necessary for learning and memory via 
neuropeptidergic and hormonal pathways. It does not directly innervate the hippocampus but can 
reach the hippocampus through indirect synaptic inputs. (Wyss et al., 1979). There have long been 
reports of the time-of-day effects on memory formation (Holloway and Wansley, 1973; Tapp et 
al., 1981; Fekete et al., 1985). In recent decades, studies have revealed diurnal oscillations of 
circadian clock genes as well as signaling cascade components such as the cAMP-MAPK-CREB 
pathway that regulate both circadian rhythms and memory formation (Iyer et al., 2014). Here, we 
investigate another shared circadian property between the SCN and hippocampus: a diurnal 
oscillation in redox state.   
Using long-term ratiometric imaging of redox cofactors, we show, for the first time, an 
oscillation of redox state with a period of close to 24 h in a rat hippocampal slice. This redox 
oscillation can be sustained in an isolated hippocampal slice for at least three days. Furthermore, 
the hippocampal redox rhythm is completely out-of-phase from that of the SCN, with early night 
being most reduced. This is an interesting discovery as the expression of circadian clock genes in 
the hippocampus and SCN are also in anti-phase (Wang et al., 2009). The rat, a nocturnal animal, 




during the day and less active at night regardless of the animal’s temporal niche. In both the 
hippocampus and SCN, the redox oscillation appears to align with neural activity levels and the 
molecular clockwork. Although there have been no reports of a diurnal redox rhythm in the 
hippocampus, there is a slim body of evidence for daily rhythms in antioxidant enzyme activity in 
the brain. Glutathione peroxidase (GSH-Px) and catalase activity levels show diurnal rhythms in 
the rat brain and hippocampus (Baydas et al., 2002; Fonzo et al, 2009). Taken together, these data 
suggest that there is a temporal pattern of redox activity in the brain.  
 In the rat SCN, Wang et al. found a rhythm in neuronal membrane properties with the 
resting membrane potential being more depolarized during the subjective day when the SCN is 
more reduced and more hyperpolarized in the subjective night when the SCN is more oxidized. 
SCN neurons are most hyperpolarized at CT 14 when the SCN is also in its most oxidized state. 
In this study, we found the hippocampal CA1 neurons are more hyperpolarized during the 
subjective day and more depolarized in the subjective night. Hippocampal CA1 neurons are most 
depolarized at CT 14 when the hippocampus is in its most reduced state. Our data show that like 
the SCN, hippocampal CA1 neurons exhibit circadian rhythms in membrane excitability in 
alignment with the rhythm in redox state. Furthermore, GSH-induced changes in Vm are CT-
dependent in both the SCN and hippocampus CA1 neurons and show opposite trends. These data 
show not only is there a redox oscillation in the hippocampus but that it could regulate membrane 
excitability of CA1 neurons.  
Other aspects of hippocampal neuronal activity have been shown to be redox-sensitive. N-
methyl d-aspartate receptor (NMDA-R) function is responsive to the redox environment and thiol 
reducing agents have been shown to potentiate NMDA-R activity (Aizenman et al., 1989) This 




shown to contain sites of redox sensitivity in NMDA receptors (Kohr et al., 1994; Sullivan et al., 
1994). The increase and decrease in activity that accompanies reduction and oxidation of cysteine 
residues is a possible mechanism of NMDA-R modulation.  Furthermore, there is evidence that 
NMDA-R activity is coupled to the glutathione system to adjust antioxidant capacity and maintain 
redox balance. Highly active neurons generate more ROS and have a higher demand for GSH, 
leading to increased GSH biosynthesis. Conversely, blocking NMDA-R activity results in 
decreased GSH biosynthesis (Baxter et al., 2015). These findings were not limited to just the GSH 
antioxidant system. In cultured rat neurons, increased synaptic activity via NMDAR elevated 
antioxidant capacity of the thioredoxin-peroxiredoxin system and blockade of synaptic NMDAR 
activity depressed antioxidant capacity (Papadia et al., 2008).  
 One of the most striking aspects of the hippocampal redox oscillation is its relationship to 
the SCN. Oscillations of neural activity, clock gene expression, redox state, and rhythms in 
membrane electrical properties all exist in both brain regions and are in anti-phase. An important 
unanswered question is whether these hippocampal oscillations are dependent on the SCN. There 
is some evidence that cycling elements in the hippocampus may depend on a functional SCN and 
core molecular clock. Per2::LUC bioluminescence rhythms persist for several days in the 
hippocampal slice without input from the SCN or other brain regions. However, such input may 
be required to maintain synchronization and amplitude of rhythms. The oscillation of Per2 in the 
dentate gyrus can be abolished by lesions of the SCN that also abolished locomotor activity rhythm 
(Lamont et al., 2005). Cycling of MAPK and adenylyl cyclase activity in the hippocampus appears 
to be SCN-dependent, as ablation of the SCN eliminated the diurnal oscillation of both (Phan et 
al., 2011). Furthermore, the hippocampus of Bmal1-/- mice does not exhibit a diurnal rhythm in 




light on the presence of hippocampal redox oscillation in animals with clock gene knockouts or 
















































Figure 4.1 The hippocampus has a redox oscillation with a period close to 24 h. Left: imaging 
was performed on the CA1 region of the hippocampus. Right: ratiometric fluorescent redox 
imaging for 72 h performed with a two-photon laser-scanning microscope. Excitation wavelength 
was set to 730 nm; 2 windows of emission at 430-500 nm and 500-550 nm were recorded 
simultaneously. Ratio of FAD (500+ nm) / NAD(P)H (400+ nm) plotted against time (h) show an 























Figure 4.2 The hippocampus is most reduced at CT 14, opposite of the redox state in the SCN 
at CT 14. A. A representative western blot of glutathiolation levels at CT 2, 6, 10, 14, 18, 22 using 
rat hippocampal slices. BioGEE incorporation was lowest at CT 14 and higher during the 
subjective day B. Glutathiolation levels in rat SCN over 5 time points. Highest level of BioGEE 
incorporation, reflecting the most oxidized state, was at CT 14 (Wang et al., 2012). C. DHA/AA 
ratio in rat SCN over 5 time points. Greatest oxidized/reduced ratio at CT 14 indicates most 
oxidized state is at CT 14 (Wang et al., 2012). D. Quantification of all blots assayed for BioGEE 
incorporation, glutathiolation levels were 68.12 ± 11.61% at CT 2, 84.74 ± 8.9% at CT 6, 90.15 ± 
4.57% at CT 10, 28.06 ± 3.6% at CT 14, 75.33 ± 9.43% at CT 18, and 52.43 ± 5.5% at CT 22. 
Glutathiolation was lowest at CT 14 in the hippocampus, suggesting that it is most reduced and 
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Figure 4.3 The SCN is more reduced during the day and oxidized at night while the 
hippocampus is more oxidized during the day and reduced at night. The SCN and 
hippocampus of the same animal have opposite redox states at CT 6 and CT 14. A. DAB staining 
of the SCN showed low BioGEE incorporation at CT 6 and high BioGEE incorporation at CT 14, 
reflecting a reduced state at CT 6 and oxidized state at CT 14. B. DAB staining of the hippocampus 
showed high BioGEE incorporation at CT 6 add low BioGEE incorporation at CT 14, reflecting 






















Figure 4.4 Circadian oscillation of membrane properties in rat SCN neurons and rat 
hippocampal CA1 neurons. Mean Vm and redox-induced D Vm display opposite patterns across 
the day in SCN and CA1 neurons. A. Whole-cell patch clamp recording of rat SCN neurons at 5 
CTs showed mean membrane potential (Vm) is most depolarized at CT 7 (Wang et al., 2012). B. 
Whole-cell patch clamp recording of rat CA1 neurons at 5 CTs showed Vm is most hyperpolarized 
at CT 7 (-75.98 ± 1.77 mV) and most depolarized at CT 14 (-68.84 ± 0.64 mV); One-way ANOVA, 
Tukey’s HSD, *p < 0.05 **p < 0.01, n = 8-19/CT (Naseri, unpublished). C. Glutathione (GSH) – 
induced change in Vm of SCN neurons at 5 CTs showed the greatest  D Vm at CT 11 (Wang et al., 
2012). D. GSH – induced change in Vm of CA1 neurons at 4 CTs showed the greatest  D Vm at CT 
10 – 12; One-way ANOVA, Tukey’s HSD, *p < 0.05 **p < 0.01, n = 4-11/CT (Naseri 














CONCLUSIONS AND FUTURE DIRECTIONS§ 
 
 
Discussion and conclusions 
Cellular redox encompasses the dynamic regulation of reactive oxygen species (ROS), 
antioxidants, and redox sensitive metabolic cofactors. ROS have been viewed historically as toxic. 
There are many studies regarding their detrimental effects to the body and contributions to disease 
and aging. However, there is increasing evidence that ROS signaling is integral to a myriad of 
normal cellular processes and signaling pathways (Knapp and Klann, 2002; Borquez et al., 2016; 
Prieto-Bermejo et al., 2017). ROS generation and redox homeostasis are no longer only relevant 
as sources of oxidative stress. Mounting evidence in the past few years show circadian rhythms in 
redox state is an intrinsic dynamic feature of all cell types and may contribute to daily regulatory 
processes.  
The balance between generation of ROS and availability of antioxidant defense systems in 
the cell is reflected in the redox state. There is increasing evidence that small changes in ROS are 
relevant in the regulation of many cellular processes and pathways. Many proteins, including ion 
channels, can be modified by oxidizing or reducing reactions. The discovery of endogenous and 
conserved circadian redox oscillations brings time-of-day significance to all cellular processes that 
are susceptible to redox regulation. The discovery of a near-24-h oscillation of redox state in the 
SCN revealed that cellular metabolic state could modulate neuronal excitability, an integral 
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component of SCN timekeeping, via modification of redox-sensitive K+ channels (Wang et al., 
2012). These results demonstrate that redox homeostasis is dynamic, displays circadian 
characteristics, and may play a role in the regulation of daily rhythms of electrically excitable cells.  
 In mice and rats, light stimuli early in the subjective night causes a phase delay while light 
stimuli late in the subjective night causes a phase advance. This bifurcating pathway is mediated 
by the ryanodine receptor (RyR) in the early night and soluble guanylate cyclase (sGC) in the late 
night (Mathur et al., 1996; Ding et al., 1998; Weber et al., 1995). However, the mechanisms of 
how selective activation of RyR or sGC occurs at different times of night is still unclear. Yu et al. 
showed that flipping the redox state in early and late night from oxidized to reduced and reduced 
to oxidized, respectively, could also flip the direction of glutamate-induced phase shifting of 
neuronal activity rhythms in SCN slices (Yu, 2007). This is unsurprising as both RyR and sGC are 
known to be sensitive to redox modification, with RyR being most active under oxidizing 
conditions and sGC most active under reducing conditions (Marengo et al., 1998; Xu et al., 1998; 
Sun et al., 2008; Braughler et al., 1983; Sayed et al., 2007).  
In this body of work, we further demonstrate that SCN redox state regulates directionality 
of clock phase resetting behavior by light in vivo. Using stereotaxic intra-SCN cannulation, we 
were able to directly alter the SCN redox environment of mice. We observed that flipping the 
redox environment from oxidized to reduced in the early night blocked the light-induced phase 
advance in wheel-running rhythms. As discussed in chapter 2, the light-induced phase delay was 
not flipped to phase advance as in neuronal activity of isolated SCN slice recordings. This is most 
likely due to the physiological complexity of intact animals and contributions from other brain 
regions to circadian behavior.  These data provide further evidence that redox state is an important 




The molecular clockwork keeps track of circadian time. However, in order for the SCN to 
respond to external cues to direct behavior, other timekeeping mechanisms are required. SCN 
neuronal electrical rhythms are essential for the expression of clock genes and reinforcement of 
synchrony. There have been numerous studies on the regulation of cellular redox state by the 
circadian molecular system as outlined in chapter 1. However, little is known about the 
contribution of the electrical rhythm to redox state in the SCN. The rhythm of glucose consumption 
in the SCN is aligned with neuronal activity levels, giving rise to the possibility that the peak in 
neuronal activity in midday contributes to the metabolic environment of the SCN (Schwartz and 
Gainer, 1977; Schwartz et al., 1980).  
In chapter 3, we examined the effects of blocking and shifting the peak of neuronal firing 
on the SCN redox environment. We blocked Na+-dependent action potentials with TTX in mid-
subjective day (CT 7) and observed dampening of the rise in oxidation at CT 14. These results 
suggest the peak in oxidation in early night of the redox rhythm is affected by the daytime peak in 
neuronal activity. Furthermore, we phase-advanced the peak of neuronal firing by 6 h with cGMP 
and observed a phase shift of the peak in oxidation from CT 14 to CT 18 and CT 22. The 
relationship between neuronal activity rhythms and redox rhythms remains unclear due to the 
contribution of both metabolic processes and ROS regulation to overall cellular redox state. It is 
possible that, in addition to neuronal activity, cGMP-mediated changes in clock gene expression 
contributes to changes in redox state via ROS production and regulation. Future experiments that 
allow direct manipulations of neuronal activity and real-time observations of redox rhythms are 
needed to clarify this relationship. However, based on this data, there is evidence that SCN redox 




Since the pioneering work of Hodgkin and Huxley, the scientific community has developed 
deep insights into neuronal membrane dynamics (Hodgkin et al., 1952). Neuronal excitability is 
directly linked to ion channel activity, and a change in permeability of ions across the plasma 
membrane can lead to significant changes in resting membrane potential.  The electrical properties 
of neurons and other excitable cells rely on many different types of voltage-gated, ligand-gated, 
and leak channels that are permeable to ions such as Na+, K+, Cl-, and Ca2+. Membrane potential 
(Vm) is determined by the differential distribution of these ions. Ion channels are regulated by a 
vast number of ligands, post-translational modifications, and other mechanisms. They are 
susceptible to modulation by phosphorylation, second messengers, gaseous signaling molecules 
such as carbon monoxide (CO) and nitric oxide (NO), and by the redox environment (Hille,1994;  
Misonou et al., 2004; Peers et al., 2015; Patel and Sesti, 2016).  
Intrinsic circadian oscillations of signaling molecules exist in the SCN and hippocampus, 
opening windows of excitability and susceptibility. Cyclic changes that gate activity have been 
termed "iterative metaplasticity" to describe states permissive for plasticity mechanisms that are 
expressed as daily cycles (Iyer et al., 2014). In nucleated cells, the molecular circadian clock is 
reciprocally connected to the redox system. These interactions produce daily rhythms in redox 
state which can then modulate neuronal activity via regulation of ion channels. Thus, day/night 
differences in redox state may play a role in the generation of daily changes in brain states that 
underlie the potential to establish long-lasting changes in brain function that we know as memory. 
Indeed, changes in the redox state have been found to modulate cognitive decline (Massad and 
Klann, 2011; Paula-Lima et al., 2014).  
Wang and colleagues demonstrated that circadian redox environment of the SCN can 




first and, to our knowledge, only example of the modulation of neuronal excitability by redox state 
in a circadian-dependent manner in mammals until now. In our study, we show that there is a 
circadian redox oscillation in the rat hippocampus antiphase to the SCN redox oscillation and a 
diurnal difference in neuronal membrane excitability. Furthermore, like in the SCN, redox state is 
capable of modulating hippocampal neuronal excitability. There are numerous reports of redox 
regulation of a number of ion channels that contribute to cellular excitability in the heart and 
peripheral nervous system. It is likely that circadian rhythms in redox state contribute to regulation 
of neuronal excitability in other brain regions. In addition, the circadian system is present in all 
tissues and cellular redox state has emerged as a contributor to tissue-specific rhythmicity. The 
redox oscillation may have the potential to contribute to the orchestration of ion channels that 
underlie electrical activity in all excitable cells throughout the body, enabling a nuanced 
fluctuation of excitable states. Further understanding of the molecular groundwork and timing 
mechanisms of the metabolic redox oscillator and its relationship to the transcription-translation 
oscillator is important.  
Taken together, our work demonstrates the importance of circadian redox rhythms in the 
maintenance of circadian rhythmicity on organismal and cellular levels. We propose a model for 
the interdependencies of the three main arms of circadian rhythm generation and maintenance: the 
transcription-translation feedback loop, the rhythm in electrical excitability, and redox oscillation 
(Fig. 5.1). In this paradigm, redox rhythms act as both input and output of circadian rhythm 
generation. Circadian redox rhythms are dependent on an intact core molecular clock (Wang et al., 
2012; O’Neill and Reddy, 2011) and, conversely, redox state is capable of modifying clock gene 
expression (Rutter et al., 2001; Carter et al., 2016; Lee and Kim, 2013; Hirano et al., 2017). Redox 




et al., 2012) and hippocampus as shown in chapter 4. In the SCN, neuronal activity may have an 
effect on redox oscillation as shown in chapter 3.  Together, these interlocking oscillations generate 
day/night differences in redox state which impact neuronal activity by differentially contributing 
to membrane excitability.  
Future directions  
There have been many advancements made in the study of redox rhythms in the last several 
years and we are just beginning to understand its role in circadian clockwork. Most of the studies 
being done in this field rely on peripheral cells and transformed fibroblasts as a model system. Our 
work is focused primarily on the SCN, which is unique in its role as an autonomous oscillator and 
“master clock” with robust daily cycles of neuronal activity and gene expression. We show that 
redox state plays key roles in circadian timekeeping and may be affected by neuronal activity in 
addition to the core molecular clock. Beyond the SCN, our data clearly demonstrate that circadian 
redox oscillation exists in the hippocampus and is capable of modulating neuronal membrane 
properties in a diurnal fashion. It is highly likely that this phenomenon exists in other brain regions 
and future studies exploring the extent of redox oscillations and its effects will be instrumental to 
understanding of the endogenous forces that contribute to activity in those regions. Furthermore, 
diurnal rhythms in redox potential translates into oscillation of the capacity to manage oxidative 
stress. Thus, further study of the regulation of redox cofactors by the circadian clock is important 
for the understanding of antioxidant defense systems. This is especially relevant for the brain, 
which is vulnerable to oxidative stress and neurodegeneration (Floyd and Hensley, 2002; Uttara et 
al., 2009).  
A major limitation to the work in this thesis is the lack of a consistent method for real-time, 




NADH sensors that can be utilized for long-term monitoring of endogenous redox fluctuations will 
be useful in future studies (Huang et al., 2016; Roma et al., 2017). Two recent studies reported that 
inhibition of the pentose phosphate pathway (PPP) can phase-shift as well as alter clock gene 
expression (Rey et al., 2016; Putker et al., 2017). Using real-time bioluminescence reporting of 
clock genes, both groups demonstrated that metabolic perturbations could alter the amplitude of 
clock gene expression and result in phase shifts but reported conflicting results regarding whether 
it can affect the period of circadian gene expression. This is an important distinction to make 
because regulation of the circadian period is a core mechanism of timekeeping while perturbations 
to amplitude and phase may be more of an accessory regulator. More work is required to determine 
the true extent of metabolic influence on the core molecular clock. Additionally, both studies 
utilized cultured cells such as human osteosarcoma and immortalized mouse fibroblasts. It would 
be interesting to observe the effects of metabolic and redox disturbances on clock gene expression 
in the SCN, a tissue with more robust timekeeping mechanisms.  
Extending beyond the CNS, endogenous redox oscillations can have modulatory effects on 
other excitable cells in the body. For instance, there is a great deal of research on how the heart 
responds to ROS. It has been shown that the redox environment can affect cardiac excitability via 
modulation of Ca2+, Na+, and K+ ion channels (Aggarwal and Makielski, 2013). Furthermore, a 
growing number of studies are focused on the relationship between redox and the pain pathway, 
specifically, the effects of redox modulation of ion channels and excitability in peripheral sensory 
neurons (Nelson et al., 2005; Jagodic et al., 2007; Evans and Todorovic, 2015). Exploration of 
these connections can shed light on the role of cellular redox in circadian timekeeping and its role 











Figure 5.1 Day-night oscillation of the redox environment modulates neuronal excitability. 
Proposed model for the interdependencies of the three main arms of circadian rhythm generation 
and maintenance. Circadian redox rhythms are dependent on an intact core molecular clock and 
redox state is capable of modulating clock gene expression. Redox state can regulate neuronal 
membrane excitability by modulation of ion channels in the SCN and hippocampus. In the SCN, 
neuronal activity may have an effect on redox oscillation. These oscillations generate day/night 
differences in redox state which differentially contribute to neuronal membrane excitability by the 
































ENDOGENOUS BIOTIN AND THE CHALLENGES OF USING BIOTINYLATED 
GLUTATHIONE AS A REPORTER OF REDOX STATE 
 
INTRODUCTION 
Many oxidant-sensitive proteins have reactive cysteines containing thiols that, once 
oxidized, are highly reactive and can react with GSH to form protein-GSH mixed disulfides. The 
transient incorporation of GSH into cellular protein in an oxidizing environment has been well-
established. Using biotinylated glutathione ethyl ester (BioGEE), we were able to quantify this 
reversible glutathiolation. The extent of BioGEE incorporation is dependent upon the 
concentration of endogenous GSH and redox potential in the cell, and can thus be used as a 
reflection of overall redox state. This method has some drawbacks; the entire lane is quantified for 
BioGEE content without distinguishing between individual bands and it is not known exactly what 
is being quantified.  
Biotin is an essential B vitamin and a cofactor of carboxylase enzymes such as pyruvate 
carboxylase and acetyl-CoA carboxylase (Jitrapakdee and Wallace, 2003). Its specific and high 
affinity binding to avidin and streptavidin has been exploited for numerous applications. Biotin’s 
small size (244.3 daltons) reduces steric hindrance and does not seem to affect molecular function. 
As a result, biotin is a widely-used tool in molecular biology. However, it is distributed throughout 
the body and endogenous biotin can be a confounding factor without the proper controls.  
Although the distribution of biotin in tissues has not been well studied, several groups have 
found that endogenous biotin is detected in significant quantities in the central nervous system 




redox state by measuring incorporation of BioGEE. For this assay, samples were incubated in 
BioGEE at specific time points and collected. The lysate is then analyzed for BioGEE 
incorporation by western blot with an HRP-conjugated anti-biotin antibody. The anti-biotin 
antibody does not discriminate between endogenous biotin and biotinylated proteins and thus can 
produce false positive bands.  
Two former students of the lab used BioGEE as a measurement of overall redox state. In 
each of their blots, there were three strong and persistently present bands (Fig. A.1A). I also 
observed these bands in my blots and was curious about their identity (Fig. A.1B). There have 
been reports of strong bands at 120 kDa and 75 kDa detected in western blots of cerebellar tissue 
with an anti-biotin antibody (Yagi et al., 2002). These results suggest there are biotin-complexed 
proteins in the CNS that can be picked up by western blotting. Western blots were run with brain 
tissue not incubated in BioGEE and probed the membrane with an anti-biotin HRP-conjugated 
antibody. Two strong bands were observed at 125 kDa and 75 kDa, with a lighter band at 40 kDa 
(Fig. A.1C). These bands correspond to the three bands consistently seen in BioGEE blots. To 
account for endogenous biotin in the BioGEE assay, I ran samples without BioGEE incubation 
under the same conditions to quantify endogenous biotin levels. Endogenous biotin does not 
appear to show day/night variation in the SCN or hippocampus, nor does treatment with TTX alter 
the level of endogenous biotin in the SCN. Therefore, we can conclude that the presence of 









MATERIALS AND METHODS 
Animals 
Long Evans/BluGill rats between 8-16 weeks of age were used for this study. Breeding 
colonies were generated and maintained at the University of Illinois at Urbana-Champaign. Rats 
were housed under standard conditions on a 12 h light 12 h dark (LD) schedule and given food 
and water ad libitum. All animal procedures were approved by the UIUC Institutional Animal Care 
and Use Committee.  
Brain slice preparation 
Rats were sacrificed un-anesthetized during the day. To isolate the SCN, a 500 µm-thick 
coronal hypothalamic brain slice containing the region of interest was made on a mechanical tissue 
chopper. The SCN was then isolated with a 2 mm-diameter tissue punch, taking as little of the 
optic nerve as possible. To isolate the hippocampus, a 500 µm-thick coronal brain slice was on a 
mechanical tissue chopper. The hippocampus was then isolated with a scalpel.  
TTX treatment  
Rat SCN slices were maintained in a tissue chamber perfused with EBSS saturated with 
95% O2/5% CO2 at 37°C. Tissue slices were perfused with control EBSS or 0.5 µM TTX in EBSS 
at CT 6 and collected and flash frozen on dry ice at CT 14 for evaluation of endogenous biotin 
levels.  
Measurement of endogenous biotin  
Brain slices were maintained in a tissue chamber perfused with EBSS saturated with 95% 
O2/5% CO2 at 37°C for at least one hour before collection. Samples were flash frozen on dry ice 




(50 mM Tris pH 7.5, 150 mM NaCl, 1mM EDTA, 0.2% SDS, 1% NP-40, 0.5% sodium 
deoxycholate) with 1X cOmplete protease inhibitor cocktail (Roche, Basel SUI) on ice and 
mechanically homogenized. After 2 min incubation on ice, samples were centrifuged at 14,000 
RPM and the supernatant was transferred to a clean tube. Protein concentration was determined 
by BCA protein assay (Pierce, Rockford IL). Total protein (25 µg/sample) was resolved in 8% 
SDS-PAGE and transferred to nitrocellulose membrane (Bio-Rad, Hercules CA). Membranes 
were probed with 1:2000 mouse anti-biotin peroxidase antibody (Cellsignaling, Danvers MA) 
overnight and developed with SuperSignal chemiluminescent substrate (Pierce, Rockford IL). 
Blots were stripped with Restore Western Blot Stripping Buffer (Thermofisher, Rockford IL) and 
re-probed with anti-a-tubulin antibody (Cellsignaling, Danvers MA). Level of endogenous biotin 
was determined quantifying overall intensity of the entire lane over the band intensity of tubulin. 
 
RESULTS 
Endogenous biotin accounts for approximately half of the density of quantified BioGEE in 
rat SCN 
 Comparison of endogenous biotin in reduced SCN slices incubated with BioGEE in EBSS 
and incubated in control EBSS at CT 7 showed that bands of endogenous biotin (46.54 ± 1.15 %) 
accounts for approximately half of the density of the BioGEE lane (86.09 ± 4.92 %) (Fig. A.2, p 
< 0.001, Student’s t-test, n = 3-4).  
Endogenous biotin levels in the rat SCN does not show a day/night difference  
 Comparison of endogenous biotin in reduced rat SCN slices incubated with EBSS at CT 7 
(87.64 ± 4.18 %) and CT 14 (84.32 ± 5.8 %) showed no significant differences between the two 





Endogenous biotin levels in the rat SCN is not changed by TTX incubation  
 Comparison of endogenous biotin in reduced SCN slices perfused with 0.5 µM TTX in 
EBSS (66.13 ± 7.81 %) and in EBSS alone (67.55 ± 11.21 %) from CT 6 to CT 14 showed no 
significant differences in biotin levels (Fig. A.4, p > 0.05, Student’s t-test, n = 4). 
Endogenous biotin levels in the rat hippocampus does not show a significant day/night 
difference 
 Comparison of endogenous biotin in rat hippocampal slices incubated with EBSS at CT 7 
(84.63 ± 5.92 %) and at CT 14 (66.64 ± 3.72 %) showed no statistically significant differences 
between the two time points (Fig. A.5, p > 0.05, Student’s t-test, n = 3-4).  
Extra bands at CT 18 and CT 22 in cGMP experiments are endogenous biotin  
We have noticed the presence of an extra 60 kDa band in the western blots faintly at CT 
18 and more strongly at CT 22 of SCN slices kept in chambers for up to 48 h used for cGMP 
experiments. The band is present in blots of SCN tissue that have not been incubated with BioGEE 
and may be associated with endogenous biotin that is complexed with carboxylases (Fig. A6A). 
The presence of this extra band of endogenous biotin could be due to carboxylase degradation at 
the later CT times. To control for the possibility that the extra band corresponding to biotin-bound 
carboxylases may cofound the quantification of glutathiolation, all bands of endogenous biotin 
were subtracted from the total lanes. We found that even without these bands, the pattern in 













Figure A.1 Anti-biotin antibody used for BioGEE assay picks up endogenous biotin on 
western blot. A. Western blot for BioGEE incorporation from a former lab member, with strong 
bands at 120 kDa and 75 kDa and lighter band at 40 kDa (Wang et al., 2012). B. Western blot for 
BioGEE incorporation done by me, with with strong bands at 120 kDa and 75 kDa and lighter 
band at 40 kDa. C. Western blot showing endogenous biotin using anti-biotin antibody with no 



































Figure A.2 Endogenous biotin accounts for approximately half of the density of the BioGEE 
lane. Left: Representative western blot of samples incubated with BioGEE and without for 
endogenous biotin. Right: Comparison of endogenous biotin in SCN slices incubated with BioGEE 
in EBSS and incubated in control EBSS at CT 7 show that bands of endogenous biotin (46.54 ± 
1.15 %) accounts for approximately half of the density of the BioGEE lane (86.09 ± 4.92 %); 































































Figure A.3 Endogenous biotin levels in the rat SCN does not show a day/night difference. 
Left: Representative western blot of endogenous biotin at CT 7 and CT 14. Right: Comparison of 
endogenous biotin in rat SCN slices incubated with EBSS at CT 7 (87.64 ± 4.18 %) and CT 14 
(84.32 ± 5.8 %) showed no significant differences between the two time points; Student’s t-test, p 














































Figure A.4 Endogenous biotin in the rat SCN is not changed by TTX incubation. Left: 
Representative western blot of endogenous biotin at CT 14 in SCN slices perfused with and 
without TTX. Right: Comparison of endogenous biotin in reduced SCN slices perfused with 0.5 
µM TTX in EBSS (66.13 ± 7.81 %) and in EBSS alone (67.55 ± 11.21 %) from CT 6 to CT 14 






















































Figure A.5 Endogenous biotin levels in the rat hippocampus does not show a significant 
day/night difference. Left: Representative western blot of endogenous biotin in the rat 
hippocampus at CT 7 and CT 14. Right: Comparison of endogenous biotin in rat hippocampal 
slices incubated with EBSS at CT 7 (84.63 ± 5.92 %) and at CT 14 (66.64 ± 3.72 %) showed no 













































Figure A.6 Extra band of endogenous biotin does not alter results of cGMP experiments. A. 
Representative western blot of samples incubated with BioGEE and showing endogenous biotin 
using anti-biotin antibody with no BioGEE incubation. A previously unseen band appears at 
approximately 60 kDa and is present in blots probed for endogenous biotin at CT 22. B. 
Quanitification of blots assayed for BioGEE incorporation at CT 2, 6, 10, 14, 18 of rat SCN slices 
treated with 0.5 µM of a cGMP at CT 18 of the previous day. One-way ANOVA with Tukey’s 
HSD, *p < 0.05 ***p < 0.001, n =6-8/CT. C. Data from A.6B with endogenous biotin bands at 
120 kDa, 75 kDa, 60 kDa, and 40 kDa subtracted from quantified lanes. One-way ANOVA with 
Tukey’s HSD, **p < 0.005 ****p < 0.0001, n =6-8/CT. D. Quanitification of blots assayed for 
BioGEE incorporation at CT 10, 14, 18, 22 of rat SCN slices treated with 0.5 µM of a cGMP at 
CT 18 of the previous day. One-way ANOVA with Tukey’s HSD, p > 0.05 n = 4-6/CT. E. Data 
from A.6D with endogenous biotin bands at 120 kDa, 75 kDa, 60 kDa, and 40 kDa subtracted from 
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